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Cancer is a devastating disease and has recently become the leading cause of death in
western countries, representing an immense public health burden. When it comes to
cancer treatment, chemotherapy is one of the main pillars, especially for advanced stage
tumors. Over the years, natural compounds have emerged as one of the most valuable
resources for new chemotherapies. It is estimated that more than half of the currently used
chemotherapeutic agents are derived from natural compounds. Usually, natural
compounds are discovered empirically and an important limitation of introducing new
anti-cancer natural products is lack of knowledge with regard to their mechanism of action.
Recent data has proven that several natural compounds may function via modulating the
expression and function of non-coding RNAs (ncRNAs). NcRNAs are a heterogenous
class of RNA molecules which are usually not translated into proteins but have an
important role in gene expression regulation and are involved in multiple tumorigenic
processes, including response/resistance to pharmacotherapy. In this review, we will
discuss how natural compounds function via ncRNAswhile summarizing the available data
regarding their effects on over 15 types of cancer. Moreover, we will critically analyze the
current advances and limitations in understanding the way natural compounds exert these
health-promoting effects by acting on ncRNAs. Finally, we will propose several hypotheses
that may open new avenues and perspectives regarding the interaction between natural
compounds and ncRNAs, which could lead to improved natural compound-based
therapeutic strategies in cancer.
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INTRODUCTION
MicroRNAs and Long Non-Coding RNAs in
Humans
Almost 2 decades have passed since it has been discovered that
about 98–99% of the human DNA is not following the central
dogma of molecular biology (i.e., only about 1% of the DNA is
actively transcribed into proteins) (The ENCODE Project
Consortium, 2012). Part of the non-protein-coding genome,
which was initially considered “junk DNA”, was later on
discovered to be pervasively transcribed (Palazzo and Lee,
2015) into RNA molecules, and the quest of revealing its
functions was started.
Nowadays, a plethora of physiological and pathological
functions of the non-coding RNA (ncRNA) are known.
Thousands of papers describe the new functions of these
previously ignored transcripts (Dragomir M. P. et al., 2018).
Based on their size, using an arbitrary selected length of 200
nucleotides, ncRNAs have been divided into small non-coding
RNAs (sncRNAs) (<200 nt) and long non-coding (>200 nt)
(lncRNAs). The most studied class of ncRNAs is a particular
subtype of sncRNAs called microRNAs (miRNAs). MiRNAs,
approximately 22 nt in length, typically bind the 3’
untranslated region (3’UTR) of mRNAs, further inhibiting
their translation into proteins. Worth mentioning is also that
most mRNAs are targeted by multiple miRNAs and each miRNA
can target several mRNAs, forming complex regulatory networks
(Dragomir M. et al., 2018). An additional layer of complexity to
these regulatory networks is the involvement of lncRNAs (or
other non-coding genes) that can bind and sponge miRNAs,
interfering with their canonical function of mRNA suppression.
Hence, it seems that there is a pool of miRNAs that can bind both
other ncRNAs and mRNAs, and everything depends on the
stoichiometry of these molecules. Interestingly, this
observation was first made in plants. In Arabidopsis thaliana,
high levels of the non-coding transcript IPS1 lead to the
sequestration of miR-399, which consequently induces the up-
regulation of its target, PHO2 mRNA (Franco-Zorrilla et al.,
2007). This interplay is perceived as a unifying theory, connecting
the non-coding world and the coding world, being plausible
especially in plants (Paschoal et al., 2018).
In the past decade, we have also witnessed some atypical
miRNA mechanisms of action. For example, some miRNAs bind
to their target mRNAs, inducing their translation rather than
inhibiting it, while other miRNAs activate Toll-like receptors
(TLRs) (Dragomir M. P. et al., 2018). Therefore, an altered
miRNA transcriptome will generate an altered proteome.
Moreover, miRNAs, in a similar way as small hormones, can
function in intercellular signaling pathways in a paracrine or
endocrine fashion, being packed into exosomes or bound to
proteins/lipids for short and long-distance transport (Pardini
and Calin, 2019). These “traveling miRNAs” can be altered in
various pathological states and reflect most of the circulating
ncRNA transcriptome.
A special subtype of sncRNAs are those arising from introns,
which act as non-canonical miRNAs and were therefore termed
“mirtrons”. Deregulation of these mirtrons is involved in various
human pathologies. Also, in plants, these molecules might have
miRNA regulatory roles. MirtronDB is an initiative of collecting
available data on these molecules (Da Fonseca et al., 2019).
LncRNAs, as mentioned, are >200 nt in length, but can also
be several kilobases long. They have a complex secondary
structure including double stem loops and cloverleaf
elements, being polymorphic in form, which enables them to
carry out a wide range of functions (Novikova et al., 2012).
LncRNAs are capable of regulating gene transcription, directly
binding proteins and RNA molecules, acting as post-
transcriptional regulators and signaling regulators (Statello
et al., 2021). LncRNAs also influence chromatin remodeling
(Dragomir et al., 2020a). Surprisingly, in recent years, it was
observed that numerous lncRNAs, circular RNAs and a few
miRNA precursors are translated into functional micropeptides
that play a role in immunity, development and cancer
(Dragomir et al., 2020b; Othoum et al., 2020). From a
phylogenetic standpoint, lncRNAs can be extremely
conserved, being termed “transcribed ultraconserved regions”
or they can be primate-specific, often harboring short repetitive
regions called pyknons (Rigoutsos et al., 2017; Dragomir et al.,
2020a). Over the years, other forms of ncRNAs with various
functions have been described and new ones are currently under
investigation. For more information about other classes and the
main functions of ncRNAs, we refer to Cech and Steitz (2014)
and Pardini et al. (2019).
The role of ncRNAs in cancer is one of the most extensively
studied fields of non-coding transcripts. Currently, we can
consider that ncRNAs play functional roles in all 12 canonical
hallmarks of cancer, but also in emerging cancer traits like
oncogenic neurogenesis (Amit et al., 2020). For example, the
super-oncogenic miR-21 is overexpressed in several types of
cancer and induces proliferation, migration, invasion, and
metastasis (Javanmardi et al., 2017) and the super-tumor
suppressor miR-34 family members are dysregulated in a
plethora of cancers and are known to inhibit metastasis by
blocking epithelial-mesenchymal transition (EMT) (Zhang L.
et al., 2019). An important role in deciphering the function of
ncRNAs are the multiple databases that provide crucial
information regarding their interacting molecules, structure,
function etc. (Maracaja-Coutinho et al., 2019). For example, a
better understanding of the role of ncRNAs in cancer will stem
from the analysis of their secondary structure, which will provide
additional mechanistic insights. A tentative to provide a curated
resource on this topic has been recently done by the RNAcentral
Consortium which provides the largest database regarding
ncRNA spatial organization for >13 million molecules
(RNAcentral Consortium et al., 2021).
While we continue to understand more and more about the
role of specific ncRNAs in different types of cancer, from a
translational perspective, these molecules have a promising
future as diagnostic biomarkers and therapeutic tools in cancer
(Petrescu et al., 2019). Additionally, we observe that the timeline
of miRNA discoveries is related to the plant world and oncology
(Dragomir M. P. et al., 2018; Li J. et al., 2019), providing a new
understanding about potential new plant based therapeutic tools
in cancer therapy (Figure 1).
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From Plants to Chemotherapy
Serendipity, which represents the “finding of interesting or
valuable things by chance”, together with recurrent efforts, are
the best words to historically describe the discovery of most
chemotherapeutic compounds (Mann, 2002). In the first half of
the 20th century, the main cancer treatment dogma was based on
radiation and surgery. Research into usage of chemicals as anti-
cancer agents emerged based on empirical observations. For
example, spilled mustard gas from a bombed ship in Bari in
World War II induced extreme leukopenia, as observed in
depleted bone marrow and lymph nodes of exposed
individuals. At the same time, the dietary effects of folic acid
were discovered, subsequently leading to the development of
folate antagonists as therapeutic agents. Such discoveries
opened the first avenues to chemotherapy. Among them, the
most notable is methotrexate. In addition, the discovery of the
effects of thiopurines and 5-fluorouracil (5-FU) in cancer induced
a shift of paradigm in cancer treatment, marking the transition
from surgical treatment to the modern “chemotherapy”. An
important landmark that needs to be mentioned was the
foundation of the “Cancer Chemotherapy National Service” in
1955 in the United States, which started a new era of substance
research, where natural compounds where screened and then
tested (DeVita and Chu, 2008).
Plants are the main source of natural compounds discussed in
this review. We will use the term “phytochemicals” to refer to
plant secondary metabolites that fulfill a broad range of functions
e.g., in the defense against herbivores and pathogens, in the
interaction with pollinators, in plant-plant chemical
communication or in the protection against high light or UV
radiation, drought or other abiotic threats. Since plants cannot
actively change their location, they have to overcome
inconvenient conditions rather than switching to more
convenient places. Being embedded in such complex ecological
relationships, plants evolved a staggering diversity of chemical
compounds enabling them to optimize their sessile lifestyle to
withstand specific pressures. This gave rise to a huge source of
molecules, including some with potential health benefits to
humans. Knowing that compounds with potential uses in
cancer therapy are the result of a stress-induced shift in plant
metabolism toward a defense reaction, appropriate techniques
can be used in controlled horticulture and agriculture to enrich
crops with these bioactive compounds. Exposing the plant to a
short and controlled stress treatment will stimulate biosynthesis
of these compounds without reducing yield (Geilfus, 2019).
The structure and relative quantity of phytochemicals vary not
only between species but even among different populations of the
same species and tissues therein (Moore et al., 2014). In the
context of medical research generally and cancer research
specifically, plant genetic diversity and ecological diversity, the
main drivers of chemical diversity in secondary metabolites, are
thus invaluable resources.
With the development of adequate models for testing these
compounds, more and more natural products from a variety of
sources, belonging to a wide range of chemical classes have been
screened in order to find new agents. This way, the functions of
phytochemicals previously used in traditional medicine have been
explained. These findings laid the ground for improvement, as
starting from the original molecules found in nature, more potent
and effective chemical analogs have been synthesized by techniques
such as combinatorial chemistry (Cragg and Pezzuto, 2016).
Since the second half of the 20th century, the approach on
oncologic treatment has changed, as more and more natural
products known from traditional medicine were shown to be
effective in treating or at least slowing down cancer. The
precursors of the podophyllins which are used today, with
etoposide and teniposide being the most representative ones,
stem from the mayapple plant (Podophyllum peltatum L.), which
Native Americans have been using in the treatment of skin warts.
Likewise, Catharanthus roseus (L.) G. Don (syn. Vinca rosea L.), a
plant that has been used as a remedy in traditional Asian
medicine, yields potent anti-cancer drugs nowadays. The
isolation of paclitaxel from the Pacific yew tree (Taxus
brevifolia Nutt.) and, later on, of the more efficient analog
docetaxel from the European yew (Taxus baccata L.),
revolutionized the standard approaches of oncologic care, as
FIGURE 1 | The timeline of miRNA discoveries is related plant sciences and oncology; providing a new understanding about potential new plant based therapeutic
tools in cancer therapy [Lee et al. (Lee et al., 1993), Wightman et al. (Wightman et al., 1993), Calin et al. (Calin et al., 2002), Reinhart et al. (Reinhart et al., 2002), Franco-
Zorilla et al. (Franco-Zorrilla et al., 2007), Poliseno et al. (Poliseno et al., 2010), Fabbri et al. (Fabbri et al., 2012), Zhang et al. (Zhang et al., 2012), Lauressergues et al.
(Lauressergues et al., 2015), Fang et al. (Fang J. et al., 2017), Liu et al. (Liu H. et al., 2020), Dragomir et al. (Dragomir et al., 2020b), and Othoum et al. (Othoum et al.,
2020)].
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they have been shown to be efficient against breast, pancreatic
and lung cancer. Likewise, the topoisomerase inhibitors
topotecan and irinotecan are also of plant origin, derived from
Camptotheca acuminata Decne., a tree species native to China,
and are part of standard treatment protocols of different cancers.
At the same time, research initiatives also focused on discovering
chemotherapeutic agents from other sources besides plants. For
example, two of the chemotherapeutical agents frequently
used–mitomycin and doxorubicin–are derived from microbial
sources. Likewise, cytosine arabinoside (cytarabine), commonly
used in pediatric cancers, is derived from amarine sponge (Mann,
2002).
While for many well-stablished natural compounds the main
mechanism of action in cancer is already known, for newer
compounds the mechanisms still need to be elucidated.
Additionally, alternate mechanisms are being investigated.
New discoveries over the last 2 decades proved that older and
newer natural products convey their functions in cancer
treatment via modulating ncRNA expression (Izzotti et al.,
2012). In this review, we sum up recent literature focused on
investigating the effects of natural compounds/phytochemicals
through ncRNAs on different cancers, discussing both cancers of
the adult age and pediatric cancers. From this, we have identified
both open fields for research and putative phytochemicals whose
potential for human health promotion might be worth pursuing
in depth. As most studies regarding phytochemicals and cancer
have focused on miRNAs and lncRNAs, we will only focus on
these two classes of ncRNAs.
Sources and Classes of Natural
Compounds
A natural compound is any organic product that is synthesized by
a living organism. As stated above, the main sources of natural
compounds are terrestrial plants, marine macroorganisms and
microorganisms (both terrestrial and marine). In this section,
chemicals derived from each of these sources will be briefly
addressed.
In terms of their role in human diets, phytochemicals are
defined as bioactive substances found in fruits, leaves, stems,
tubers, roots and other parts of the plant, providing beneficial
health effects. Unlike other human nutrients such as proteins, fats
or minerals, most phytochemicals are not indispensable for
human life, but, among other beneficial properties, they have
considerable value in cancer prevention, and as adjuvants in
cancer therapy (Gullett et al., 2010; Sak, 2012).
Beside the terrestrial plant kingdom, marine life is also a major
source for a variety of bioactive agents. These can be extracted
from marine macroorganisms like tunicates, sponges, soft corals,
and mollusks. Noteworthy examples would be cytarabine and
vidarabine, two agents widely used in chemotherapy (Montaser
and Luesch, 2011; Victor and Sharma, 2015).
Likewise, microbes produce a wide range of potentially useful
compounds. Bacterial proteins and peptides and, more recently,
chemicals isolated from marine sediment bacteria include
promising natural compounds that show an anti-proliferative
activity and could be employed as anti-cancer agents. Antibiotics,
bacteriocins, enzymes, non-ribosomal peptides (NRPs) and
toxins are the main groups of bacteria-derived chemicals
(Karpinski and Adamczak, 2018).
Natural compounds can be classified into different groups
based on their chemical structure and biological characteristics
including phenolic compounds, terpenes, carotenoids, saponins,
alkaloids and organosulfur compounds, among others (Budisan
et al., 2017). Table 1 offers an overview of the chemical classes
and subclasses encompassing the natural products discussed in
this review, which are almost exclusively of plant origin. It should
be stressed that this is not an exhaustive table attempting to
categorize the entire spectrum of known natural compounds, but
only a selection relevant in the context of ncRNA-mediated anti-
cancer effects. The reader may also acknowledge that there are
also disciplines that favor a different way of classification or
grouping. In the next section, we will present recent findings
about specific natural compounds in the context of ncRNA
modulation and cancer therapy, following the order used in
Table 1.
PHENOLIC COMPOUNDS
Plant phenolic compounds are secondary metabolites bearing
structures with one or more hydroxyl groups attached to at least
one aromatic ring. They are generally known for their
antioxidative properties, with the number and position of the
hydroxyl groups leading to a variation in their bioactivity, e.g., in
the antioxidative potential. In plants, they represent precursors of
cell wall components and fulfill a multitude of other functions
including the response to different biotic and abiotic stressors.
For instance, phenolic substances are known to have repellent
properties against herbivores, diminish herbivore digestive
ability, protect against fungal and bacterial infections and are
involved in the response to wounding, drought, salinity and
modified or stressful light exposure (Bhattacharya et al., 2010;
Geilfus, 2019).
Very often, phenolic compounds extracted from plants are
referred to as “polyphenols”, both in commercial and in scientific
communication. However, this term is sometimes misused to
even include compounds featuring a single hydroxylated
aromatic ring, which would be correctly referred to as
monophenols. In this review, we use definitions and
classifications proposed by Quideau et al. (2011) as guiding
principles for presenting plant phenolic compounds in a
systematic fashion. This can be a challenging task, since
common classifications of plant phenolic compounds based on
biogenetic aspects yield categories that cannot be globally
considered monophenols or polyphenols, despite this being a
very common practice. For instance, flavonoids, curcuminoids
and stilbenoids are commonly referred to as “polyphenolic
compounds”, even though these classes also contain
compounds with less than two hydroxylated benzene rings.
For this reason, we will discuss these classes of phytochemicals
directly under the umbrella term of “phenolic compounds”, while
only using the term “polyphenols” when all criteria proposed by
Quideau et al. (2011) are met. These authors define polyphenols
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as “plant secondary metabolites derived exclusively from the
shikimate-derived phenylpropanoid and/or the polyketide
pathway(s), featuring more than one phenolic ring and being
devoid of any nitrogen-based functional group in their most
basic structural expression.”
Phenolic Acids and Other Monophenols
Phenolic acids are monophenolic compounds and are some of the
most abundant dietary antioxidants in everyday human diets,
consumed as fresh or processed fruits, e.g., raspberries,
blueberries, cranberries, apples, and grapes (including wine)
and also present in tea and coffee (Manach et al., 2004). This
class of compounds is mainly divided in two subgroups:
hydroxybenzoic acids and hydroxycinnamic acids (Velderrain-
Rodríguez et al., 2014; Kumar and Goel, 2019). Like other
phenolic compounds, phenolic acids do not only display
antioxidative properties upon human consumption, but also
show antimicrobial, antiviral, anti-mutagenic, or anti-
tumorigenic activity (Shahidi and Yeo, 2018; Kaurinovic and
Vastag, 2019; Valanciene et al., 2020). As intermediate substrates
of the plant-intrinsic phenylpropanoid pathway, some phenolic
acids are chemical precursors of many other monophenolic or
polyphenolic phytochemicals presented here.
Gallic acid is a trihydroxybenzoic acid distributed in a wide
range of plants such as sumac species (Rhus spp.), oaks (Quercus
spp.) and others. Moreover, it is present in wine. During
vinification, gallic acid travels from the oak barrel into the
wine (Giménez Martínez et al., 2001). It is so stable, that it
survives the fermentation and ripening process and year-long
storage. A study on the effects of gallic acid on chondrosarcoma
cells showed that this compound reduces viability, inhibits
migration and induces apoptosis. Bcl-2 levels were decreased
and Bax levels were increased and caspase-3 and -9 activation was
enhanced. Moreover, miR-518b was up-regulated in
chondrosarcoma cells treated with gallic acid, suggesting its
implication in apoptosis and inhibition of migration, but no
molecular pathway was directly described (Liang et al., 2014).
Salidroside, a glucoside of themonophenolic compound tyrosol
extracted from the golden root plant (Rhodiola rosea L.), was used
to treat nephroblastoma tumor cell lines. Apoptosis was promoted,
cleaved caspase -3 and -9 levels were elevated, p53 and p21
expression was increased and decreased expression of vimentin,
matrix metalloproteinase 2 (MMP-2) and cyclin D1 was observed.
The phosphorylation levels of p65, Iκ-Bα, PI3K, AKT and mTOR
were increased in treated cells, while transfection with miR-891b
up-regulated cyclin D1 and down-regulated p53 and p21.
Salidroside was presumed to inhibit growth and migration
through down-regulation of miR-891b, leading to inactivation of
PI3K/AKT/mTOR and NF-κB signaling pathways, but the direct
molecular targets await clarification (Li H. et al., 2019).
Paeonol is a simple phenol found in peonies (Paeonia spp.)
and other plants, that is used in traditional Chinese medicine
(TCM). In a study on chondrosarcoma cells, Horng et al. (2014)
showed that although paeonol did not decrease cell viability nor
induce apoptosis, it exhibited anti-proliferative effects as
evidenced by reduced protein-kinase C delta and c-Src
phosphorylation activity. MiR-141 levels were elevated in
treated cells while its suppression decreased the effects of
paeonol. However, no mechanistic links were revealed between
miR-141 and the protein-kinase C delta and c-Src pathways.
Shikonin is a naphthoquinone found in the purple gromwell
plant (Lithospermum erythrorhizon Siebold and Zucc.), whose
dried roots are used in TCM. Shikonin was found to reduce
retinoblastoma cell proliferation by up-regulating miR-34a and
miR-202, both well-known anti-oncogenic miRNAs. There is
evidence for the inhibited proliferation being connected with
miR-34a and miR-202 repressing the oncogene protein MYCN
(Su et al., 2018). The inhibitory relationship between MYCN and
miR-34a has been evaluated in lung cancer, where miR-34a
increased chemosensitivity to cisplatin via inhibition of MYCN
(Song et al., 2017).
Flavonoids
Flavonoids are a wide family of phenolic compounds found in
almost all plant organs including leaves, fruits or flowers. In
addition to their role in the response against diverse biotic and
abiotic stress factors, they are often responsible for the aroma and
pigmentation of flowers and fruits (Erdman et al., 2007; Panche
TABLE 1 | Major classes and subclasses of organic chemicals, and their specific natural compounds, whose potential role in cancer therapy has been summarized in this
review. N/A, not available.
Major compound classes Subclasses
Phenolic compounds Phenolic acids and other monophenols




Related compounds: Lignans, flavaglines
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et al., 2016). This is to attract pollinators (in flowers) or to avoid
being eaten by insects (in leaves). In terms of plant metabolism,
these compounds have been described as hybrids, stemming from
a combination of the phenylpropanoid and the polyketide
pathways. For the synthesis of phenolic compounds, this is
considered to be the most productive metabolic route in
plants, with more than 8,000 compounds produced by
different plant species being counted as belonging to the
flavonoid family (Quideau et al., 2011). Flavonoids discussed
in this review belong to several major flavonoid subclasses such as
the flavones, flavanones, isoflavones, flavanols and chalcones.
In the case of flavones, there are multiple active chemicals that
have been tested for anti-cancer properties. Among them,
apigenin and luteolin are the most thoroughly studied.
Apigenin is a common flavone found in a range of plants,
includingMatricaria spp. (commonly known as chamomile), that
displays important anti-tumor properties (Salehi et al., 2019). A
study by Gao et al. (2018) found miR-520b, which physiologically
acts as a tumor suppressor, to be up-regulated in apigenin treated
hepatocellular carcinoma (HCC) cells. In turn, miR-520b targets
ATG7, regulating autophagy and, in the cited study, leads to
increased chemo-sensitivity to doxorubicin treatment. Apigenin
treatment also showed increased miR-16 levels in glioma cell
lines, which subsequently targeted and decreased BCL2
expression and down-regulated the NF-kB/MMP9 pathway
(Chen X. J. et al., 2016).
As for luteolin, plants rich in this natural compound have
been used in TCM for the treatment of hypertension,
inflammatory skin diseases or cancer (Lin et al., 2008). In vitro
and in vivo studies on hepatoma cells revealed that luteolin
treatment promotes apoptosis and tumor suppression through
up-regulation of miR-6809-5p which down-regulates Flotillin 1
by directly binding to the 3′UTR of Flotillin-1 gene mRNA (Yang
et al., 2019a). Flotillin 1 is a membrane receptor protein that is
considered to promote metastasis and tumor invasion by
influencing the Erk1/2, p38, JNK and NF-κB/p65 signaling
pathways (Lin C. et al., 2011; Cao et al., 2016).
In pancreatic cancer cells, luteolin treatment is associated with
down-regulation of miR-301-3p, which directly targets caspase-8,
an initiator of the extrinsic apoptosis pathway. Also, luteolin
treatment and knockdown of miR-301-3p sensitized pancreatic
cancer cells to the tumor necrosis factor (TNF)-related apoptosis-
inducing ligand (TRAIL) (Moeng et al., 2020). This is a potent
apoptosis inducer of the TNF cytokine superfamily, which was
also tested as a recombinant anti-cancer agent, but with reported
high resistance rates after repeated treatments (Wong et al.,
2019).
Mir-34a, which has a well-known tumor suppressor role, has
been shown to be epigenetically down-regulated by aberrant CpG
methylation of its promoter region in multiple cancers, including
gastric cancer (Lodygin et al., 2008). In a study on gastric cancer
cell lines, the reduced expression of miR-34a was reversed by
treatment with luteolin. Mir-34a was then shown to target and
reduce expression of the BCL-2 protein, leading to apoptosis
induction (Wu et al., 2015a).
Moreover, pleiotrophin (PTN), a growth factor that is highly
expressed in several cancers associated with poor prognosis (Jee
et al., 2016; Ma et al., 2017), has been found to be modulated by
luteolin in colorectal cancer (CRC) cells through the up-regulation
of miR-384, which binds to PTN 3′-UTR (Yao et al., 2019).
In human glioma cells, treatment with luteolin increased miR-
124-3p expression, activated apoptosis through MAPK and the
death receptor pathway. It also promoted autophagosome
initiation following an increased ratio of LC3B II to LC3B I
and decreased p62 levels. Although no mechanistic target was
identified, the authors suggest PIM1 as a potential miR-124-3p
target, an important protein for cell proliferation and apoptosis
(Brasó-Maristany et al., 2016; Tursynbay et al., 2016; You et al.,
2019).
Luteolin also showed synergistic effects with silibinin, a
flavonolignan found in milk thistle seeds (Silybum marianum
(L.) Gaertn.). In glioblastoma (GBM) cells, this specific co-
treatment produced better results than conventional
chemotherapy [bis-chloroethyl nitrosourea or temozolomide
(TMZ)]. Co-treatment with these two flavonoid compounds
increased apoptosis and reduced autophagy. This is owed to
luteolin’s capacity of inhibiting PKCα and up-regulating
mTOR and p62, along with silibinin’s ability to inhibit
inducible nitric oxide synthase (iNOS). Their anti-oncogenic
activity, regardless of p53 GBM status, is mediated by miR-7-
1-3p overexpression. Mechanistically they showed that, miR-7-1-
3p decreases in vivo the expression of XIAP, a potent anti-
apoptotic protein (Chakrabarti and Ray, 2016).
Baicalein is a flavone found in the roots of plants such as the
Baikal skullcap (Scutellaria baicalensisGeorgi). Zhang et al. treated
osteosarcoma cell lines with baicalein and noted increased miR-
183 expression. The authors showed that this miRNA directly
modulated the expression of Ezrin, an intracellular protein which
connects the cell wall via the actin cytoskeleton. By decreasing
Ezrin, baicalein treatment in this study led to decreased
proliferation, invasion and migration (Zhang J. et al., 2018).
These findings are additionally supported by another study of
Zhang et al. (2014) who showed that Ezrin up-regulates
N-cadherin levels and ERK pathway activity to promote
osteosarcoma invasion. This mechanism has also been
highlighted in other studies on different osteosarcoma and
gastric cancer cells respectively (Zhu et al., 2012; Cao et al., 2014).
Naringin is the glycosidic form of the flavanone naringenin
and can be found in citrus fruits. This compound was used by Tan
et al. in human chondrosarcoma cells lines. The authors observed
an up-regulation of miR-126, which was shown to regulate the
expression of vascular cell adhesion molecule-1 (VCAM-1), a
protein involved in cell motility, which probably accounted for
the observed repression of migration and proliferation in this
study (Tan et al., 2014).
Formononetin, an isoflavone derived from red clover
(Trifolium pratense L.), has been investigated by Hu. et al., who
used it to treat osteosarcoma cell lines and tumor bearingmice (Hu
and Xiao, 2015). This study noted decreased expression levels of
miR-375 and an increased Bax/Bcl-2 ratio, which probably
accounts for the observed apoptosis induction in vitro and for
the tumor mass shrinkage in vivo. Notably, formononetin also acts
as a phytoestrogen and has been shown to act on the estrogen
receptor-beta (ERβ) with anti-tumor effects on ER positive breast
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cancer cells (Chen et al., 2013). ER β is known to have anti-tumor
effects in various tumors including osteosarcoma (Yang et al., 2017;
Yang Z. M. et al., 2019). In breast cancer cell lines, miR-375 is up-
regulated and inhibition resulted in decreased ERα signaling (de
Souza Rocha Simonini et al., 2010).
The flavanols epigallocatechin gallate (EGCG) and
(−)-epicatechin gallate (ECG) are important antioxidants
from green tea and, as catechins, chemical precursors of
condensed tannins (proanthocyanidins) (Quideau et al., 2011).
In a study on osteosarcoma cell lines by Liangdong et al., EGCG
increased apoptosis by cell cycle arrest in the G1 phase (Jiang L.
et al., 2014). Arrest in the G1 phase was also observed in prostate
cancer studies, without involvement of p53 (Gupta et al., 2003),
while in leukemic cells the apoptotic effects were mediated
through p53, p21 and Bax (which showed increased
expression) and down-regulation of Bcl-2-α (Harakeh et al.,
2008). Jiang et al. co-treated osteosarcoma cells with miR-126
and EGCG and showed that, in contrast to aforementioned
findings, miR-126 did not interact with the mTOR pathway,
without inducing the G1 phase arrest of the cell cycle. However,
miR-126 enhanced the anti-tumoral effect of EGCG.
Mechanistically, it remains unclear if EGCG can act as a miR-
126 inducer (Jiang L. et al., 2014). However, studies on gastric
cancer cell lines (Liu et al., 2014) and endothelial cell lines (Sui
et al., 2014) showed that miR-126 regulates PLK2, PI3KR2, Crk,
PI3K and Akt, respectively, and these pathways may be
dysregulated in osteosarcoma cells as well.
In neuroblastoma cell lines, treatment with EGCG and ECG
increased several tumor-suppressive miRNAs such as miR-7-1,
miR-34a and miR-99a and decreased a number of oncogenic
miRNAs such as miR-92, miR-93 and miR-106b. Overexpression
of miR-7-1 followed by co-treatment with EGCG and fenretinide,
a synthetic retinol derivate, increased apoptosis by promoting
activation of the caspase-3 and calpain pathways. In contrast,
miR-93 overexpression reduced the efficacy of fenretinide-EGCG
co-treatment, promoted proliferation, with decreased caspase-8,
caspase-3, tBid and calpain levels and increased expression of the
apoptosis inhibitor survivin (Chakrabarti et al., 2012; Chakrabarti
et al., 2013). In nasopharyngeal carcinoma cells, EGCG
modulated miR-296 and decreased cancer cell migration. This
effect was associated with down-regulation of signal transducer
and activator of transcription 3 (STAT3) activation mediated by
miR-296 (Lin et al., 2020).
Xanthohumol is a chalcone found in hops (Humulus lupulus
L.). Ho et al. treated a U87-MG GBM cell line with xanthohumol
and observed reduced invasiveness induced by the down-
regulation of stromal interaction molecule 1 (STIM1). MiR-
4725-3p was up-regulated in treated cells and it was shown that
the effects of xanthohumol were mediated via miR-4725-3p, which
binds directly to the 3′-UTR of STIM1 (Ho et al., 2018). STIM1 is
an important protein in cellular calcium metabolism, and
inhibition of STIM1 has favorable effects on proliferation and
apoptosis (Liu et al., 2011). Furthermore, Chen et al. also treated
glioblastoma cells with xanthohumol and noted apoptosis
induction, as well as mitochondrial dysfunction and generation
of radical oxygen species. The group demonstrated that
xanthohumol up-regulated miR-204-3p via ERK/c-Fos pathway
and went on to hypothesize IGFBP2 (insulin-like growth factor
binding protein 2) as a potential target of this miRNA. IGFBP2 is
implicated in the regulation of proliferation by modulation of
AKT/Bcl-2, and its down-regulation through miR-204-3p may
account for the observed cytotoxicity (Chen P. H. et al., 2016).
Curcuminoids
Curcuminoids are phenolic compounds containing two benzene
rings and are derived from the name-giving compound curcumin,
featuring some variations in functional groups. Curcumin has
been isolated from the turmeric plant (Curcuma longa L.) and is
responsible for the distinctive bright yellow color of turmeric.
Plants accumulate this insecticidal and fungicidal compound in
the storage roots and other organs to protect them from being
eaten or infected, respectively (Kim et al., 2003). A number of
studies on different cancer cell lines reported curcumin down-
regulating miR-21 levels with pro-apoptotic and anti-
proliferative effects. In a diffuse large B-cell lymphoma cell
line Liu et al. (Liu K. et al. (2017)) revealed VHL (Von
Hippel-Landau), a tumor suppressor gene, as a target for miR-
21. They then verified the involvement of curcumin by reversing
all the salutary effects of this natural compound either through
miR-21 overexpression or VHL siRNA transfection. In CRC,
Mudduluru et al. (2011) showed that treatment of two CRC cell
lines with curcumin down-regulated the miR-21 expression via
regulation of activation protein 1 (AP-1) transcription factor.
Subsequently, a known miR-21 target in CRC (Asangani et al.,
2008), programmed cell death protein 4 (PDCD4) was shown to
be up-regulated. Induction of cell cycle arrest in G2/M, in vitro
anti-proliferative effects and in vivo anti-metastatic effects by
curcumin, might be a consequence of PDCD4 regulation via miR-
21. Additionally, PDCD4 locus is coding also for an antisense
lncRNA and an intronic miRNA which could play an additional
role in the regulatory pathway.
Studies on breast cancer (Wang X. et al., 2017; Esmatabadi
et al., 2017) and glioma (Yeh et al., 2015) have also reported
curcumin down-regulating miR-21 expression, but without
proposing a specific mechanism by which it does so, or
possible targets of miR-21. Working with a GBM model, Tan
et al. (2018) designed a micelle loaded with curcumin andmiR-21
antisense nucleotide and reported increased effects compared to
both curcumin treatment and miR-21 antisense nucleotide
treatment alone. This was found both in vitro and in vivo, as
evidenced by increased apoptosis and lower tumor volume,
respectively. Tan et al. did not test for any miR-21 targets in
this experiment, but showed elevated levels of phosphatase and
tensin homolog (PTEN) and PDCD4, two known targets of miR-
21 in other cancers (Cirino et al., 1991; Asangani et al., 2008).
In retinoblastoma cell lines, curcumin up-regulated miR-99a
and reduced JAK/STAT activity in a miR-99a dependent manner,
although the precise target of miR-99a was not identified (Li Y.
et al., 2018). Sreenivasan et al. also treated retinoblastoma cells
with curcumin and found that miR-22 was up-regulated and,
upon subsequent transfection, cell migration was inhibited
(Sreenivasan et al., 2012). This study, along with Patel et al.
(2011) further showed that miR-22 negatively regulates Erbb3
which is up-regulated in various neoplasms including
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retinoblastoma (Chakraborty et al., 2007). Yu et al. (2015) showed
that curcumin up-regulates miR-138 and down-regulates miR-
186 in osteosarcoma cells. Moreover, they revealed Smad4, NF-
kB p65 and Cyclin D3 as targets of miR-138 and demonstrated
that curcumin inhibits these genes in a miR-138 dependent
manner. It is also worth mentioning that miR-22 was also up-
regulated, but downstream exploration was not undertaken.
Curcumin was used by Yin et al. (2018), Tahmasebi Mirgani
et al. (2014) and Wu et al. (2015b) on GBM cells. Yin revealed that
miR-326 and curcumin had complementary effects, with curcumin
increasing miR-326 expression and miR-326 augmenting
curcumin’s anti-tumor activity by increasing apoptosis,
inhibiting proliferation and migration (Yin et al., 2018).
Furthermore, an inhibition of the SHH/GLI1 signaling pathway
was observed, a result also described by other studies employing
curcumin (Du et al., 2013) or miR-326 (Jiang Z. et al., 2014). In
addition, a combined therapy decreased tumor volume and
increased survival in a glioma mouse model population. While
no specific target of miR-326 was identified by Yin in this
experiment, SMO was evidenced as a direct target of miR-326
in another experiment on glioma cells (Du et al., 2015). Mirgani
et al. showed that curcumin increased miR-145 expression and
subsequently down-regulated OCT4A, OCT4B1 and SOX-2 which
are known targets of miR-145 (Chivukula and Mendell, 2009; Xu
et al., 2009) and reduced cell viability by increasing apoptosis and
cell cycle arrest (Tahmasebi Mirgani et al., 2014). Because GBM is
known for resistance to therapy with temozolomide, a process
mediated through NF-kB overexpression (Lavon et al., 2007), Wu
et al. investigated whether a combination of curcumin and TMZ
would improve GBM chemosensitivity. Combination therapy
resulted in increased apoptosis compared to either TMZ or
curcumin alone and in an up-regulation of miR-146a levels
(Wu et al., 2015b). Inhibition of miR-146a, which has been
shown to negatively regulate the NF-kB pathway (Crone et al.,
2012; Sha et al., 2013), canceled curcumin’s enhancing effect on
TMZ treatment.
Stilbenoids
Stilbenoids, a family of non-flavonoid phenolic phytochemicals,
mainly play a role in fungal and UV protection in plants
(Akinwumi et al., 2018). In humans, they are known to
modulate several signaling pathways involved in oxidative stress
and inflammation, therefore these compounds could have
applications in cardiovascular protection, insulin resistance,
neurodegeneration and cancer prevention (Carter et al., 2014;
Kosuru et al., 2016; Dvorakova and Landa, 2017). One of the
richest sources of stilbenoids currently known is the genus Vitis,
which includes the grapevine Vitis vinifera L.
Resveratrol and its derivatives are the most extensively
studied compounds in this class (Rivière et al., 2012) and can
commonly be found in fruits such as red grapes and raspberries.
In plants, they act as phytoalexins that play a role in the defense
against bacterial and fungal pathogens (Tian and Liu, 2020). Xiao
et al. investigated the relationship between miR-139-5p and
resveratrol in osteosarcoma cells and discovered that
resveratrol induces apoptosis and up-regulates miR-139-5p,
with a synergistic relationship existing between the two
molecules. While miR-139-5p mimics augment the effect of
resveratrol, this effect is diminished by miR-139 inhibition. It
was shown that miR-139-5p elicits an inhibitory effect on
NOTCH1 by directly binding to the 3′ UTR (Xiao et al., 2020).
Yang et al. also treated osteosarcoma cells with resveratrol at
non-cytotoxic concentrations and revealed that proliferation and
invasiveness were inhibited in vitro and in vivo. Resveratrol up-
regulated miR-328 which in turn directly binds MMP-2 and
reduced its expression (Yang et al., 2015). Additionally, in a
different study it was further demonstrated by another research
group that miR-328-3p directly targeted MMP-16 in
osteosarcoma cells (Zhang M. et al., 2019).
In a GBM cell line, resveratrol was found to down-regulate
miR-21, in connection with a subsequent decreased
phosphorylation of the Inbitor of κB (IκB) and p50/p65
heterodimer. This has the effect of blocking their nuclear
internalization and the inability to activate the NF-kB pathway
leads to a reduction of cell viability (Li H. et al., 2013).
MiR-15a and miR-16–1 are two anti-oncogenes that inhibit
Bcl-2 and are known to be down-regulated in leukemia
(Cimmino et al., 2005; Acunzo and Croce, 2016). Resveratrol
exercised anti-tumor effects in T-cell and B-cell ALL cells by
down-regulating miR-196b and miR-1290 which are known to be
elevated in ALL lines (Zhou et al., 2017). Down-regulation of
these miRNAs resulted in up-regulation of IGFBP3 (insulin-like
growth factor binding protein 3), which was revealed to be
lowered in ALL patients compared to healthy controls. Both
miRNAs were found to bind to the 3′-UTR of the IGFBP3 gene
with inhibitory effects.
Pterostilbene is an analog of resveratrol found in almonds,
grapes and berries from the genus Vaccinium, with blueberries as
the most noteworthy source. Huynh et al. investigated the effect
of pterostilbene in CD133 + GBM stem cells with highly
expressed GRP78 (Glucose-regulated protein 78), which are
known for their resistance to therapy. Upon treatment with
pterostilbene, an increase in miR-205, as well as a decrease in
GRP78, c-Myc, TCF-4, GSK3β and vimentin levels were
discovered. These modifications translated into the disruption
of tumor sphere formation and radiation sensitization. The
authors hypothesized that miR-205 is responsible for this
down-regulation, as overexpression of miR-205 in
monotherapy yielded the same results and combination
therapy had a more pronounced effect. The findings were also
confirmed in vivo, on xenograft mice (Huynh et al., 2015).
Tannins
Tannins are polyphenolic secondary metabolites that often have
high molar masses (up to 20,000 D) and that are known for their
ability to crosslink collagen chains, an effect that is used in the
process of turning animal skins into leather (“tanning”). They are
found in a wide range of higher plant families and are responsible
for the astringent taste of many plants. Their biological role
mainly consists in protecting the plant against bacterial or fungal
infection or herbivory (acting as a repellent), therefore an increase
in tannin production is found when plants respond to these
particular situations (Khanbabaee and van Ree, 2001). Based on
their structural characteristics, tannins can be divided into several
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major groups: gallotannins, ellagitannins (often collectively
referred to as hydrolyzable tannins), condensed tannins and
complex tannins. Among these, condensed tannins (also called
proanthocyanidins), which are derived from the oligomerization
or polymerization of flavanol units, have shown promising effects
in cancer research.
Chakrabarti et al. (2016) treated GBM cells with grape seed
proanthocyanidins (GSP) and with miR-30e. Both GSP and
miR-30e in monotherapy decreased autophagy as evidenced by
reduced levels of Beclin-1 and LC3 II and increased apoptosis by
down-regulation of BIRC6 and AVEN, two important apoptosis
inhibitors. The role of autophagy, which is a physiologic process
implicated in the household of healthy cells, turns to pro-
tumoral in the context of hypoxia and starvation, by
recycling proteins which contribute to the tumoral survival
and proliferation. In the case of GSP and miR-30e, co-treatment
showed synergistic results but with no evidence of a direct
induction of miR-30e by GSP.
Related Compounds
This section presents two more compounds belonging to two
phytochemical families (lignans and flavaglines) with precursors
stemming from the phenylpropanoid metabolic network (Pan
et al., 2013; El-Seedi et al., 2018). While these particular
compounds contain aromatic rings lacking free hydroxyl
groups, they are included here, since they are biogenetically
related to plant phenolics discussed above.
Lignans are building blocks of the cell wall, but they can also
inhibit germination of competitor plants and protect the plant
through their antimicrobial activity (DellaGreca et al., 2013). One
lignan that has been studied in cancer research is schisandrin, a
compound extracted from the magnolia-vine (Schisandra chinensis
(Turcz.) Baill.). Jiang et al. (2015) found schisandrin to have an
inhibitory effect on the mTOR/MMP-9 pathway and to inhibit
glioma metastasis. In another study by Jiang et al., in which glioma
cell lines were treated with schisandrin, an increase in miR-125a-5p
expression and a decrease in the expression of the lncRNAHOTAIR
(HOX transcript antisense RNA) were observed. This modulation of
miRNA and lncRNA was associated with a lowered mTOR protein
expression. Upon transfection with a miR-125a-5p inhibitor, the
effects of schisandrin were diminished, but no further mechanistic
details were offered (Jiang Y. et al., 2017). However, a molecular
mechanism was described by Tang et al., who identified CASP2 as a
target of miR-125a-5p and found that knockdown of HOTAIR can
induce cell apoptosis via CASP2/miR-125a-5p axis (Tang et al.,
2016).
Another compound tested for its potential use in cancer
therapies is silvestrol, a flavagline produced by trees of the
genus Aglaia, which showed important anti-tumor effects in
acute myeloid leukemia (AML) cell lines. After FLT3-ITD
(FLT3 internal tandem duplication) and FLT3-wt cell lines were
subjected to silvestrol treatment, a reduction of proliferation and
colony forming capacity and an increase of apoptosis were
obtained in both cell lines. FLT3-ITD protein and miR-155
levels were decreased by silvestrol. NF-kB protein levels were
found to be also decreased, which could indicate that silvestrol
down-regulates miR-155 through NF-kB (Alachkar et al., 2013).
TERPENOIDS AND MEROTERPENOIDS
Terpenoids are a group of molecules synthesized by all kinds of
organisms (animals, plants, fungi, bacteria etc.) through either the
mevalonate (MVA) or the methylerythritol phosphate (MEP)
pathways, assuming a wide range of metabolic functions. They
are particularly diverse in plants, with higher plants possessing a
great number of enzymes specialized in terpenoid synthesis. In
plants, some terpenoids can be classified as primary metabolites,
as they contribute to essential cell functions like photosynthetic
activity or membrane stability, while others that are involved in
responses to environmental factors are counted as secondary
metabolites (Bergman et al., 2019; Tetali, 2019). The latter
category serves many functions similar to those previously
presented for phenolic compounds: defense against pathogens
and herbivores, attraction of pollinators or of natural enemies of
herbivores, response to light stress etc. In fact, terpenoids form the
most diverse group of secondary metabolites known from plants. A
large number of terpenoids are used by humans for various reasons,
including medical (e.g., as anti-malarial drugs or chemotherapy
medication) or cosmetic purposes and in the food industry
(Tetali, 2019).
Interestingly, in Arabidopsis thaliana (L.) Heynh., proper
functioning of plant miRNAs in post-transcriptional gene silencing
was shown to be dependent on terpenoid biosynthesis. As it has been
suggested, this might be due to the need for a functional MVA
pathway as a prerequisite for membrane association of Argonaute
(AGO) proteins. As AGOs and, by extension, RNA-induced silencing
complexes (RISC) are associated with membranes in both plants and
animals, this might be an interesting example of phytochemicals
influencing miRNA function through a commonmechanism in both
groups of organisms (Brodersen et al., 2012).
Terpenes represent the basic form of terpenoids. They are
derived from isoprene precursors containing five carbon atoms
and can be classified by the number of isoprene units they are
composed of, e.g., hemiterpenes (1 unit–5 C), monoterpenes (2
units–10 C), diterpenes (4 units–20 C) up to polyterpenes that
may consist of thousands to tens of thousands of isoprene units.
The term terpenoids is used to designate a broader category
which comprises terpenes and derived molecules containing
additional functional groups. This section additionally includes
terpenoid glycosides and molecules having at least a partial




α-pinene is an isomer of pinene, a monoterpene found in the
resin of coniferous plants. Xu Q. et al. (2018) and Yang J. B. et al.
(2016) showed that α-pinene induced G2/M phase cell cycle
arrest and inhibited miR-221 expression with downstream up-
regulation of CDKN1B/P27 and down-regulation of CDKN1C/
P57 in HCC cells. The mechanism through which miR-221
regulates CDKN1C/P57 and CDKN1B/P27 was not elucidated
in this study, but another study revealed that CDKN1B/P27 is a
direct target of miR-221 (Diaz-Moralli et al., 2013).
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Ailanthone is a pentacyclic diterpene lactone produced by
the tree of heaven (Ailanthus altissima (Mill.) Swingle). This
compound was used to treat a number of cancer cell lines with
proapoptotic and anti-proliferative effects and showed
regulatory activity on a number of different miRNAs. In a
study on AML cell lines (Zhang Y. et al., 2019), ailanthone
up-regulated miR-449a with inhibitory effects on the Notch and
PI3K/AKT pathways, both of which were demonstrated to be
downstream targets of miR-449a (Liu X. et al., 2018; Cheng et al.,
2018). Similar proapoptotic and anti-proliferative effects were
observed by Gao W. et al. (2019) in breast cancer cell lines,
where ailanthone up-regulated miR-148a and inhibited the
AMPK and Wnt/β-catenin pathways in a miR-148a-
dependent manner. For Hou et al. of course in a study on
lung cancer cell lines, also showed that ailanthone blocked
the PI3K/AKT pathway as well as the JAK/STAT3 pathway
in a miR-195-dependent manner, miRNA levels being up-
regulated upon treatment (Hou et al., 2019). Yang et al.
revealed that miR-21 was down-regulated by ailanthone in a
schwannoma cell line with downstream inhibition of the Ras/
Raf/MEK/ERK and mTOR pathways. MiR-21 overexpression
partly reversed ailanthone effects by increasing the expression
of Ras, Raf, p-MEK, p-ERK, p-mTOR and p-p70S6K (Yang P.
et al., 2018).
Carnosic acid is a diterpenoid found in rosemary (Salvia
rosmarinus Spenn.) and sage (Salvia officinalis L.). Liu and
colleagues induced G2/M phase cell cycle arrest and lowered
proliferation in a chronic myeloid leukemia (CML) cell line
through treatment with carnosic acid. MiR-708 was down-
regulated, but no downstream pathway mechanisms were
explored (Liu D. et al., 2018). It is worth mentioning that
miR-708 has been reported as both an oncogenic (Li X. et al.,
2013; Zhang Y. et al., 2017; Huang et al., 2018) and an anti-
oncogenic (Baer et al., 2015; Wu et al., 2016; Monteleone and
Lutz, 2020) miRNA in various other studies on leukemic and lung
cancer cells. A study using rosemary extracts on colon and
pancreatic cancer cells showed anti-cancer effects both in vitro
and in vivo (colon cancer xenografts in treated nude mice showed
reduced tumor size compared to untreated mice). In this study,
the authors showed that carnosic acid down-regulates miR-15b,
subsequently leading to overexpression of the GCNT3 gene.
However, a direct interaction between this miRNA and
GCNT3 was not identified (González-Vallinas et al., 2014).
Triptolide is a diterpenoid extracted from the Asianmedicinal
plant Tripterygium wilfordii Hook. f., which has been used in
TCM against rheumatoid arthritis and psoriasis (Bao and Dai,
2011). This compound has shown anti-cancer effects in studies
employing a variety of cancer cell lines.
In medulloblastoma cells treated with triptolide, miR-138 was
increased and proliferation, viability and migration were
inhibited. MiR-138 directly targets Cyclin Dependent kinase 6
(CDK6). Hence, a possible mechanistic explanation for the anti-
cancer effect of triptolide is the inhibition of CDK6 via miR-138
(Zhang H. et al., 2018). Furthermore, triptolide also induced the
apoptosis of osteosarcoma cells by inhibition of PTEN. MiR-181a
was up-regulated by triptolide and directly inhibited PTEN
mRNA translation (Jiang C. et al., 2017).
In CRC, treatment with triptolide down-regulated miR-191
and was associated with decreased activation of Wnt/β-catenin
and NFkB pathways. Treated cells showed increased apoptosis
and reduced migration capabilities (Qi and Li, 2019).
Nephroblastoma cells treated with triptolide showed a decrease
in KLF-4 activity (an activator of p53) and down-regulation of
PI3K/AKT and ERK pathways. KLF-4 activity was modulated by
miR-193b-3p (Hang et al., 2019).
In ALL cell lines, 21 different miRNAs were modulated by
triptolide. MiR-138-2* was the most significantly up-regulated
and miR-16–1 was the most significantly down-regulated,
supposedly accounting for the anti-proliferative effects of
triptolide noted in this study (Meng et al., 2011). Furthermore,
breast cancer cells showed decreased invasion and migration
capacity after exposure to triptolide. Triptolide up-regulates miR-
146a, which mechanistically down-regulates the expression of Ras-
related C3 botulinum toxin substrate 1 (RAC1), an important
cellular switch which is altered in cancerous states (Liu Q. et al.,
2019).
Betulinic acid is a triterpenoid found in the bark of several tree
species, most notably that of the white birch (Betula pubescens
Ehrh.), where it functions as a phytoalexin. This compound was
used to treat breast cancer cell lines by (Mertens-Talcott et al.,
2013) and (Liu et al., 2012). Both groups showed that betulinic
acid displays anti-cancer activity, as reflected in lower cell
survival, proliferation and increased apoptosis. Betulinic acid
down-regulated the transcription factors SP1, SP3 and SP4 via
miR-27a down-regulation, and the subsequent up-regulation of
its target ZBTB10. Furthermore, Liu et al. demonstrated that
betulinic acid effect on miR-27a-ZBTB10-Sp axis was CB1 and
CB2 cannabinoid receptors dependent.
Carotenoids
Carotenoids are lipid-soluble tetraterpenoid pigments fulfilling
important functions in plants, such as facilitating photosynthesis
by harvesting light energy (photons) as an antenna pigment,
protecting against high light-induced damage or signalizing fruit
ripeness. They are often responsible for yellow, orange or red
coloration in different parts of the plant (Ngamwonglumlert et al.,
2019).
One of the best-known carotenoids, β-carotene, has been tested
in colon cancer stem cells, where it reduced sphere formation and
proliferation and it was shown to act as an epigenetic regulator by
down-regulating various miRNAs, such as miR-1260b and miR-
296-3p. Mechanistically, these dysregulated miRNAs stimulated
the acetylation process, reflected by an increase in histones H3 and
H4, as well as the reduced expression levels of the DNMT3A
mRNA, resulting in DNA hypomethylation. Both these noted
effects are counteracting epigenetic modifications observed in
cancer cells (Kim et al., 2019).
In human diets, β-carotene functions as provitamin A
consisting of two retinyl groups and is transformed in the
digestive system into retinol, a form of vitamin A. Due to
some carotenoids (including β-carotene) being sources of
vitamin A, we will proceed to discuss the effects of a synthetic
isoform of vitamin A called all-trans retinoic acid (ATRA).
While it is not a natural compound itself, ATRA is synthesized
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from β-carotene (oxidative cleavage of carotenoids catalyzed by
enzyme models and beta-carotene 15,15′-monooxygenase) and,
therefore, it is a very suitable example for demonstrating the value
of developing synthetic substances inspired by natural
compounds in an attempt to optimize their known beneficial
effects.
In a recent systematic review by Lima et al. (2019), the effects
of ATRA on nine different in vitro cancer types was summarized.
In this review, miRNA expression profiles, as well as phenotypical
changes after ATRA treatment are well described for the nine
cancer forms. However, for most of the covered studies, the
mechanistic description of miRNA downstream pathways is
missing.
Nevertheless, the ATRA-induced promyelocytic leukemia
(PML) differentiation through miRNA is covered in different
studies, numerous mechanistic explanations being available. In
one study (De Marchis et al., 2009), ATRA achieved an up-
regulation of miR-342, while at the same time increased
expression levels of granulocyte colony-stimulating factor
receptor (G-CSFr) mRNA levels were noted, which in turn, were
linked to promyelocytic differentiation. Likewise, in another study
onAML lines, the research group (Lin K. Y. et al., 2011) showed that
ATRA could down-regulate the expression of the homebox protein
CDX2, stopping it from binding to the promoter region of the miR-
125b gene, hence down-regulating its expression. The down-
regulated miR-125b then stops binding to the core binding
factor β (CBFβ) gene, allowing it to be expressed, which also
accounted for the granulocytic differentiation. Interestingly, in a
different study (Zhuang et al., 2014), it was shown that CBFβ down-
regulates the expression of miR-181a which, in turn, regulates the
adenylate cyclase 9 (AC9) levels. The latter is an enzyme which
catalyzes the conversion of ATP to cAMP, which is required in the
differentiation process of the promyelocytic forms. These findings
are confirmed by a different study which showed that the
promyelocytic differentiation is miR-181a,b-dependent. In
PML, the miR-181 cluster is pathologically up-regulated
because of the PML/RARα oncogene. Upon ATRA
treatment, levels of the miR-181a,b are down-regulated. In
this study, these miRNAs were shown to bind to the 3′UTR
gene of RASSF1A, regulating its expression. While down-
regulation of RASSFA1 halted the ATRA-induced
differentiation by influencing the cyclin D1 pathway, its
overexpression led to apoptosis (Bräuer-Hartmann et al.,
2015). In non-small-cell lung cancer (NSCLC) lines, ATRA
induced the up-regulation of miR-512-5p, which in turn may be
responsible for the observed p21 mRNA and protein down-
regulation, associated with apoptosis and lesser glucose uptake
by cancer cells (Chu et al., 2016). These finding are represented
in Figure 2.
Saponins
Saponins are glycosylated triterpenoids with a wide distribution
in plants, where they are mainly associated with defense
responses against herbivores (acting as antifeedants) and
pathogens (Sawai and Saito, 2011). Most of them are
amphipathic, being intercalated in the lipid bilayers
where, among other functions, they influence membrane
permeability (Moses et al., 2014). They have also been used
for ages in traditional medicine and most compounds
used in cancer-related studies featuring ncRNAs generally
originate from TCM. The majority of the studies are
conducted on different cancer cell lines, while others also
focus on in vivo models of tumor-bearing mice.
Some of the most extensively studied saponins are
derived from the ginseng genus Panax, most commonly from
the species Panax ginseng C.A.Mey and Panax notoginseng
(Burkill) F.H.Chen. Among these compounds, the most
thoroughly investigated is Ginsenoside Rh2, which has been
shown to have anti-proliferative and/or apoptosis-inducing
properties. In glioma cell lines, Rh2 was shown to regulate
expression of different miRNAs. Especially an up-regulation
of miR-128 was noted, which was then demonstrated to
target the promoter region of E2F3a, reducing its
expression. E2Fa is a transcription factor implicated in
regulating expression of key components of the cell cycle,
which explains the noted anti-proliferative effects. Moreover,
in the same study, increasing caspase-3 levels were noted
along dose- and time-dependent induction of apoptosis
through Rh2 (Wu et al., 2011). Likewise, in prostate cancer
cell lines, miR-4295 was shown to be suppressed by Rh2,
not being able to bind to the 3′UTR region of CDKN1. This
resulted in up-regulation of p21, with known implications in cell
cycle regulation, accounting for the observed anti-proliferative
effects (Gao and Zheng, 2018).
In a study on both hepatitis B-induced HCC cell lines as well as
on tumor bearing mice, Rh2 also showed anti-proliferative
FIGURE 2 | Potential pathways by which the semi-synthetic all-trans
retinoic acid (ATRA) compound can lead to promyelocyte differentiation in
promyelocytic leukemia (PML). ATRA induces miR-342 up-regulation, which
then leads to increased expression of G-CSF mRNA. ATRA decreases
expression of homebox protein CDX2 and miR-125b as well as increases the
expression of core binding factor β (CBFβ). CBFβ can also modulate
expression levels of miR-181a and b, which in turn modulates RASSAF1/
Cyclin D1 expression, finally contributing to promyelocytic differentiation.
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potential by up-regulation of miR-491, which was shown to target
the epidermal growth factor receptor (EGFR) and by reducing its
expression to act anti-proliferative (Chen and Qiu, 2015). In one
study on NSCLC lines, Rh2 was proposed as an anti-metastatic
agent. It was shown to up-regulate miR-491, which in turn might
reverse the hypoxia (HIF-1α)-induced up-regulation of MMP-9,
contributing to the anti-migratory effect noticed in the cell lines
(Chen Y. et al., 2019).
In a study on adriamycin- and docetaxel-resistant breast
cancer cell lines, Wen et al. showed anti-proliferative effects
after treatment with Rh2. The authors hypothesized that Rh2
could reverse chemoresistance by regulating the expression miR-
222, miR-34a and miR-29a, which in turn could target effectors
implicated in chemoresistance reversal. However, no targets of
specified miRNAs were analyzed in this study, only an unspecific
increase in BAX expression levels was noted (Wen et al., 2015).
Ginsenoside Rh2 was proposed to induce apoptosis and to
prolong survival in mice with AML and the miR-21/Bcl-2
pathway (Wang and Wang, 2015). In retinoblastoma cell lines
it also showed anti-proliferative and apoptosis inducing
properties via miR-638 via PI3K/AKT/mTOR pathway (Li M.
et al., 2019).
A related compound, ginsenoside Rg3 was proposed to
influence the cancer cell metabolism in two studies on ovarian
cell lines by reversing the Warburg effect. In one of the studies,
Rg3 decreased expression of several lncRNAs including lncH19,
which was shown to target miR-324-5p. The increased miR-324-
5p levels inhibited pyruvate kinase isozyme 2 (PKM2), which
accounted for the noted metabolic change (Zheng et al., 2018). In
a similar follow-up study, the same research group noted that Rg3
inhibited the expression of DNA methyltransferase 3A
(DNMT3A), which, in turn, reduced methylation of many
genes, among these also the promoter region of miR-532-3p
leading to the up-regulation of this miRNA. Further on, this
miRNA was shown to target hexokinase 2 (HK2), having the
same consequence, Warburg effect reversal (Zhou et al., 2018).
Another similar compound, ginsenoside Rg2 was tested also
on oral squamous cell cancer (OSCC) cell lines where it showed
anti-proliferative and anti-metastatic effects by down-regulating
miR-221. Low levels of miR-221 up-regulate the
metalloproteinase inhibitor 3 (TIMP3), which in turn acts on
the PI3K/AKT andMAPK/ERK pathways. The findings were also
confirmed on tumor bearing mice (Cheng and Xing, 2019).
There is also a third type of ginsenoside that has been
investigated, ginsenoside Rd. This compound showed anti-
metastatic properties in vitro and in vivo in breast cancer via
down-regulation of miR-18a, which directly targets Smad2,
known to be implicated in cell migration (Wang P. et al., 2016).
One study showed that a mixture of ginsenosides could also
influence angiogenesis in a tissue specific manner via miR-18a,
reducing neo-vascularization in tumor tissue, while stimulating it
in cardiac tissue of the same tumor-bearing mice (Yang Q. et al.,
2014). Another study focused on the P. notoginseng extract (a
mixture of multiple ginsenosides), showed anti-proliferative
effects in vitro and in vivo also via miR-222, by targeting and
up-regulating p27 and PTEN tumor suppressors, which in turn
modulated the expression of several other oncogenes or tumor
suppressor genes in lung cancer cell lines. Results were confirmed
in vivo on inoculated mice (Yang Q. et al., 2016).
Of course, saponins known to have miRNA-dependent anti-
cancer effects are found in other plants as well, beside ginseng
species. For instance, polyphyllin VI, extracted from the Asian
plant species Paris polyphylla Sm., has been tested in murine and
human breast cancer lines and was shown to decrease miR-18a
expression, up-regulating the Receptor expressed in lymphoid
tissue (RELT)-like 2 (Rell2), which was linked to the observed
anti-metastatic effects (Wang et al., 2019).
Astragaloside IV is a saponin extracted from the root of the
Mongolianmilkvetch (Astragalus membranaceus (Fisch.) Bunge).
This compound was shown to improve tumor microenvironment
(TME) disbalance and affect EMT and migratory potential in
fibroblast derived from gastric cancers (in opposition to
fibroblasts derived from non-cancerous gastric tissue) via miR-
214 and miR-301. The two miRNAs subsequently modulate
M-CSF and TIMP2 levels, which, in turn, prevented the
expression of the pro-oncogenic factors SRY (sex determining
region Y)-box 2 (SOX2) and NANOG (Wang Z. F. et al., 2017). In
CRC, it also affected EMT through miR-134/CREB1, while it also
increased chemosensitivity through the same mechanism (Ye
et al., 2017). Cell proliferation was also reduced in CRC via miR-29c
and B7-H3 protein (Wang et al., 2018).
In another study in HCC, astragaloside IV together with
curcumin, reduced angiogenesis via miR-122 and miR-212 in
vivo, by influencing expression of several TME regulatory
molecules (FGF2, MMP2, VEGF, HGF, TF, FVII). The data
was also confirmed by microscopical vessel count (Zhang S. et
al., 2017).
There are also several saponins with anti-proliferative and
anti-migratory properties on NSCLC lines. For instance, NSCLC
cell lines treated with Tubeimoside I, have been shown to have
increased miR-126-5p expression. In turn, miR-126-5p targeted
VEGF-A and VEGFR-2, leading to reduced angiogenesis and
reduced metastatic potential (Shi et al., 2018). Still in NSCLC cell
lines, Cyclamen pseudibericum Hildebr. extract up-regulated
miR-200c which, in turn, targeted the transcriptional repressor
Zinc finger E-box-binding homeobox 1 (ZEB1), resulting in
decreased expression of E-cadherin, N-cadherin and vimentin,
reflecting the EMT-inhibitory properties of this extract (Karagur
et al., 2018).
Other saponins were found to have anti-cancer effects in
studies addressing a variety of cancer types. In hepatoma cell
lines, a saponin extacted from the plant species Ornithogalum
saundersiae Baker called OSW-1 (alternatively known as
orsaponin), in combination with doxorubicin influenced the
expression of multiple miRNAs (especially miR-142-3p),
which are known to be implicated in tumor metabolism (Jin
et al., 2013). In gastric cancer, another anti-proliferative saponin
was Platycodin D, which regulated miR-34a/surviving levels
in vitro and also in vivo (Peng et al., 2019). D Rhamnose
β-hederin from the vine Clematis ganpiniana (H.Lév. and
Vaniot) Tamura reduced breast cancer tumor cell exosome
production, exosomes which either carry genetic cargo coding
for Docetaxel chemoresistance (Chen et al., 2018b) or simply pro-
metastatic miRNAs, like miR-130 and miR-425 (Chen et al.,
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2018a). Finally, in breast cancer cell lines, Timosaponin A-III,
extracted from the plant species Anemarrhena asphodeloides
Bunge, has been shown to induce the expression of miR-200c
and miR-141, both of which may target c-Myc. This might lead to
the down-regulation of the BMI1, a protein associated a
prooncogenic phenotype in several malignancies (Gergely
et al., 2018).
Polyprenylated Acylphloroglucinols
Polyprenylated acylphloroglucinols are a peculiar class of natural
compounds that contain multiple isoprenyl or geranyl chains
stemming from the MVA/MEP biosynthetic pathways coupled to
an acylphloroglucinol core moiety derived from the polyketide
pathway. These meroterpenoid compounds are very diverse in
terms of structure and bioactivity. A subgroup with less complex
structures, monocyclic polyprenylated acylphloroglucinols
(MPAPs) is known from plant families such as Clusiaceae
(Guttiferae), Myrtaceae and Cannabaceae (Ciochina and
Grossman, 2006), while their more complex derivatives, the
polycyclic polyprenylated acylphloroglucinols (PPAPs) have
been isolated almost exclusively from the genera Hypericum
and Garcinia of the family Clusiaceae. Only two exceptions
from the families Rutaceae and Simaroubaceae have recently
been described (Yang X. W. et al., 2018).
Garcinol is a PPAP possessing a dihydroxyphenyl moiety
extracted from the fruit of the kokum tree (Garcinia indica
(Thouars) Choisy). Kokum fruits are widely used in Indian
cuisine as a souring agent and for the preparation of refreshing
drinks (Padhye et al., 2009). In pancreatic cancer cell cultures
(PANC-1SP cells), garcinol treatment effectively increased the
expression of different anti-oncogenic miRNAs: miR-200c,
miR-29b, miR-101 and miR-181. Only the activity of miR-
200c was investigated in more detail. MiR-200c shows affinity
for the 3′UTR of the NOTCH1 mRNA, with its subsequent
down-regulation leading to a reversal of cancer stemness
(including reduction of self-renewal ability) and metastasis
inhibition (Huang et al., 2017). Similarly, a study by
Parasramka et al. found the modulation of several miRNAs
by garcinol to be the mechanism behind the reduction in tumor
sphere formation. Additionally, this regulation of miRNA
expression was suggested to be involved in the attenuation of
the drug resistance phenotype when garcinol was used
alongside gemcitabine. Garcinol and gemcitabine co-
treatment modulates several miRNAs involved in canonical
cancer signaling pathways such as miR-21, miR-196a, miR-
495, miR-605, miR-638, miR-453, with gemcitabine alone
modulating only miR-605. Meanwhile, garcinol itself was
shown to up-regulate miR-453, miR-128, miR-1280 and
miR-720 expression and down-regulate miR-21, miR-495,
miR-494, miR-1977 (Parasramka et al., 2013).
The ability of garcinol to increase the sensitivity of cancer
cells to other drugs was also described in a study on
mesenchymal NSCLC cell lines (Farhan et al., 2019). Here,
garcinol treatment resulted in drug-sensitization to cisplatin
and erlotinib as well as in EMT inhibition. EMT is regulated by
several important miRNAs such as miR-200b, miR-205, miR-
218 and let-7c, all of which were up-regulated by garcinol in
these cell lines, with miR-200b and let-7c levels being the most
strongly influenced.
Furthermore, in breast cancer cell cultures and xenograft
mouse models, garcinol treatment facilitated the transition of
EMT to MET phenotype. Several miRNAs were significantly up-
regulated such as let-7 family miRNAs (let-7a, let-7e, let-7f) and
members of the miR-200 family (miR-200b, and miR-200c).
MiR-200b and mirR-200c up-regulation is associated with
decreased activity of the NF-kB signaling pathway and
provides a molecular framework for how garcinol lowers
cancer cell invasiveness (Ahmad et al., 2012).
Cannabinoids
Cannabinoids are a group of terpenophenols (meroterpenoids)
with 21 carbon atoms naturally occurring in hemp (Cannabis
sativa L.), known for their capacity to bind the cannabinoid
receptors CB1 and CB2. This characteristic offers them
psychoactive properties as well as the ability to modulate the
immune system (Widelski et al., 2017). Two very well-known
examples of natural cannabinoids are tetrahydrocannabinol
(THC) and cannabidiol (CBD).
The anti-inflammatory effects of cannabinoids, particularly of
cannabidiol (CBD) have been demonstrated in several studies on
microglial cells exposed to CBD and lipopolysaccharide (LPS).
MiR-146a, an important element of the Toll like receptor (TLR)
signaling pathway (O’Neill et al., 2011), was up-regulated by LPS
and down-regulated by CBD. In addition, pretreatment with CBD
reduced miR-146a up-regulation after exposure to LPS (Juknat
et al., 2019). A study on low-grade gliomas in a pediatric
population revealed that the low expression of the CB1
receptor and high levels of hsa-miR-29b-3p are potential
prognostic factors for involution or absence of progression
after subtotal tumor resection (Sredni et al., 2016). These
results show that further research into miR-29b-3p and
exogenous and endogenous cannabinoids is needed.
ALKALOIDS
Alkaloids are a class of natural compounds with structures
containing at least one nitrogen atom. These compounds are
immensely structurally diverse and are primarily connected to
chemical defense mechanisms developed by plants against
herbivores, pathogens or competing plants. Therefore, many
alkaloids show significant levels of toxicity (Michael, 2007).
Many are also used for medical purposes. Some alkaloids such
as vincristine and vinblastine are already being used as
chemotherapeutic agents in a number of cancers such as
Hodgkin’s lymphoma, neuroblastoma and Wilms tumor
(Moudi et al., 2013; Below and Das, 2020). Many other
alkaloids have been studied in order to ascertain their effects
either as direct anti-cancer agents or as adjuvants by increasing
chemotherapeutic sensitivity (Mondal et al., 2019).
Neferine is an alkaloid found in the seeds of the sacred lotus
(Nelumbo nucifera Gaertn.), which are used in TCM to obtain a
herbal remedy known as Lotus Plumule or Plumula Nelumbinis.
Liang et al. treated glioma cell lines with neferine and found
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increased apoptosis along with decreased cell proliferation and
migration. Neferine down-regulated miR-10b which was found to
inhibit PTEN/PI3K/AKT by targeting PTEN gene. Subsequently,
PTEN expression–an important tumor-suppressive gene-was
increased in U251 treated cells. p38-MAPK pathway was
deactivated with lower p38 phosphorylation levels following
neferine treatment via down-regulation of miR-10b (Liang
et al., 2019). However, no further inquiries regarding the
molecular target were formulated.
Liu Z. et al. (2019) also achieved anti-tumor effects with
neferine on a breast cancer cell line through down-regulation
of miR-374a. This miRNA was further shown to increase
Fibroblast growth factor receptor 2 (FGFR-2) expression.
Neferine inhibited the PI3K/AKT and MEK/ERK pathways
through the modulation of miR-374a/FGFR-2 axis leading to
reduced cell proliferation and migration and enhanced apoptosis.
Neferine also inhibited the PI3K/AKT pathway in a
gastrointestinal stromal tumor cell line by up-regulating miR-
449a levels (Xue et al., 2019).
Berbamine is an alkaloid found in the Amur barberry plant
(Berberis amurensis Rupr.). A synthetic derivative (BBMD3) of
berbamine was used by Yang F. et al. (2014) to treat glioblastoma
cell lines. Apoptosis was increased by caspase-3 and JNK-c JUN/
AP-1 pathway activation as evidenced by increased cleavage of
poly (ADP-ribose) polymerase and phosphorylation of c-Jun
and c-Fos respectively. MiR-4284 was one of several up-
regulated miRNAs, and its inhibition resulted in diminished
apoptotic effects of BBMD3. In a study on melanoma
cells, BBMD3 inhibited the STAT3 pathway (Nam et al.,
2012), but these results were not confirmed by Yang et al. in
their studies.
Matrine, oxymatrine (matrine oxide) and sophocarpine are
alkaloids found in plants of the genus Sophora of the legume
family (Fabaceae). Matrine induced apoptosis and cell cycle arrest
in a number of different cancer cell lines. In breast cancer,
matrine acted through the miR-21/PTEN/Akt pathway by
down-regulating miR-21 to induce apoptosis and cell cycle
arrest in the G1/S phase (Li et al., 2012). In a study on colon
cancer cells, matrine, by up-regulating miR-22 which was found
to target ERBB3 andMECOMmRNA. This way, matrine induced
apoptosis and G0/G1 cell cycle arrest as well as down-regulation
of the Wnt/β-catenin and MEK/ERK pathways (Liu J. et al.,
2020). MiR-126 was also up-regulated in a NSCLC cell line
treated with matrine and increased apoptosis and G0/G1
phase arrest were also observed (An et al., 2016). In
melanoma cells, matrine also up-regulated PTEN and
modulated the PTEN/Akt pathway to promote apoptosis, but
by means of down-regulating miR-19b-3p which was also found
to bind to PTEN as did miR-21 in breast cancer cells (Wei et al.,
2018).
MiR-21 was also down-regulated by sophocarpine in a
head and neck squamous cell carcinoma cell line by
inhibition of Dicer processing and resulted in increased
activity in the PTEN and p38/MAPK pathways. Beneficial
effects were obtained both in vitro with increased apoptosis
but also in vivo with growth inhibition in a mouse xenograft
model (Li W. et al., 2017).
Anti-cancer effects were also described for oxymatrine. Li
et al. (2015) found up-regulated levels of miR-29b with
downstream inhibition of MMP-2 expression in ovarian
cancer cells treated with oxymatrine. In another study on lung
cancer cells, Zhou et al. (2019) also managed to lower
proliferation both in vitro and in vivo by up-regulating miR-
520 which showed inhibitory effects on VEGF expression after
oxymatrine treatment.
Solanine and solasodine are toxic alkaloids found in some very
common representatives of the nightshade family (Solanaceae),
including tomatoes, eggplants and the fruits of potato plants.
Zhang F. et al. (2016) and Wu et al. (2018) both reported that
solanine up-regulated miR-138 with anti-proliferative and
chemosensitizing effects in lung adenocarcinoma cells and
esophageal cancer respectively. On lung adenocarcinoma cells,
solanine was cytotoxic by itself and also improved
chemosensitivity to cisplatin. Focal adhesion kinase (FAK)
levels, a protein involved in cellular adhesion that was
investigated as a potential therapeutic target for lung
(Kawashima and Kurokawa, 1983) and breast (Baraka and
Serhal, 1989; Zhang S. et al., 2017) cancer (among others),
were down-regulated. FAK was revealed to be a direct target
of miR-138 and it was shown that upon antisense transfection,
solanine manifested no anti-cancer effects.
Regarding esophageal cancer, solanine improved
chemosensitivity to 5-FU and cisplatin in a miR-138 dependent
manner. Survivin, a protein which inhibits apoptosis and is highly
expressed in tumor tissue (Sah et al., 2006), was down-regulated by
miR-138 which directly bound to its mRNA. MiR-138 antisense
transfection lifted the effects of solanine on survivin expression. In
a study on prostate cancer cells, solanine up-regulated GAS5, a
lncRNA, which was revealed to target miR-18a directly and
decrease its expression with increased radiosensitivity as a
result. GAS5 was overexpressed without solanine and, indeed,
the same proapoptotic effects were seen, however no target of
miR-18a was mentioned (Yang et al., 2019a).
The related compound solasodine down-regulated miR-21 in
a lung cancer cell line and besides inhibiting the PI3K/Akt
pathway it was shown to increase that expression of RECK
(reversion-inducing cystein-rich protein with kazal motifs).
RECK is known target of miR-21 and acts as metastasis
suppressor (Shen et al., 2017).
Capsaicin is an alkaloid that is found in Capsicum peppers,
within the Solanaceae family. By binding to capsaicin receptors in
our tongues, it triggers a sensation of heat or pungency, which
accounts for its wide use as a spice in global cuisine. CML cells
treated with capsaicin showed decreased proliferation, with
capsaicin down-regulating miR-520a-5p and, by a miR-520a-
5p-dependent mechanism, also down-regulating the STAT3
pathway (Kaymaz et al., 2014). Acting as a reactive oxygen
species (ROS), capsaicin damages DNA, which triggers cell
apoptosis through the p53/miR-34 axis, as was show in a
NSCLC cell line. It is worth mentioning that absence of p53
abolished the effects of capsaicin (Chakraborty et al., 2014).
Interestingly, capsaicin also inhibited proliferation of prostate
cancer cells, not through increasing apoptosis, rather through
inducing cell cycle arrest in the G0/G1 phase. Capsaicin up-
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regulated miR-449a, which in turn dowregulated the androgen
receptor (AR) (Zheng et al., 2015).
Ligustrazine is an alkaloid found in natto, a traditional
Japanese dish of fermented soybeans, in fermented cocoa
beans and in Ligusticum wallichii Franch., a plant of the
Apiaceae family used in TCM. A study (Xu D. et al., 2018) on
medulloblastoma cell lines showed that ligustrazine promoted
apoptosis and inhibited proliferation and invasion by inhibiting
the mTOR and PI3K/Akt pathways. Ligustrazine also up-
regulated miR-211 and although miR-211 antisense
transfection reduced ligustrazine’s inhibitory effects on the
above-mentioned pathways, no direct target of miR-211 was
evidenced.
Sinomenine is an alkaloid found in the roots of Sinomenium
acutum (Thunb.) Rehder and E.H.Wilson, a climbing plant from
East Asia used in TCM. Sinomenine showed proapoptotic effects
in prostate cancer cells by inhibition of the PI3K/Akt and JAK
STAT pathways. MiR-23a was also up-regulated by sinomenine
and antisense transfection reduced sinomenine effects on these
two pathways, but no target of miR-23a was identified (Xu et al.,
2019). In breast cancer cells, sinomenine suppressed invasion,
proliferation and also induced apoptosis by down-regulating
miR-324-5p (Song et al., 2015) and up-regulating miR-29
(Gao G. et al., 2019). Down-regulation of interleukin 4 (IL-4)
resulted in decreased miR-324-5p expression and, in turn,
CUEDC2, its reported target gene, was up-regulated. This
resulted in increased NF-kB–IkB binding, with lowered NF-kB
activity. MiR-29 up-regulation resulted in increased PDCD4
expression and downstream inhibition of the JNK and MERK/
ERK pathways.
Sanguinarine is a toxic alkaloid found in several plants of the
poppy family (Papaveraceae). In gastric cancer cells, sanguinarine
was found to down-regulate miR-96-5p and miR-29c-3p and
subsequently increase MAP4K4, a target gene of both miRNAs,
with downstream activation of MAPK/JNK pathway and
decreased tumor proliferation (Dong et al., 2019). In HCC
lines (Zhang B. et al., 2019), sanguinarine up-regulated miR-
16-2 in a p53-dependent manner with anti-proliferative effects.
Moreover, mouse HCC xenografts showed reduced tumor growth
in the same study. While no direct mRNA target of miR-16-2 was
explored, Bcl-2 and Cyclin D1 levels, two accepted targets of miR-
16 (Cimmino et al., 2005; Liu et al., 2008), were found to be
reduced.
Coptisine and dauricine are two alkaloids isolated from the
Chinese goldthread (Coptis chinensis Franch.) and the Asian
moonseed vine (Menispermum dauricum DC.), respectively.
Both showed anti-tumor effects on hepatocellular carcinoma
cells in vitro and in vivo. Coptisine was found to up-regulate
miR-122 and lower proliferation and tumor size (Chai et al.,
2018). Dauricine inhibited glycolysis via up-regulation of miR-
199 which directly targeted and inhibited hexokinase 2 (HK2)
and pyruvate kinase muscle isozyme 2 (PKM2). Treatmend with
dauricine also lead to decreased proliferation and increased
chemosensitivity to sorafenib, cisplatin and isoliensinine (Li
W. et al., 2018).
Berberine is a further alkaloid found in C. chinensis
rhizomes. This compound suppressed IL6 and STAT3 in a
multiple myeloma cell line, a possible mechanism for the
down-regulation of miR-21 was also observed. MiR-21
suppression was followed by PDCD4 overexpression with
anti-cancer effects (Luo et al., 2014). It appears berberine also
has chemosensitizing properties as shown by You et al. (2016)
and Chen et al. (2015) who increased cisplatin sensitivity by up-
regulating miR-203 and inhibiting miR-93 in a gastric cancer
cell line and ovarian cancer cell line, respectively. You et al.
revealed Bcl-w as a target for miR-203 and Chen et al. showed
that berberine elicited its effects through the miR-93-PTEN/
AKT pathway.
Lycorine is toxic alkaloid isolated from plants of the
Amaryllidaceae family, which includes popular ornamental
plants like snowdrops and daffodils. Lycorine was shown to
decrease proliferation in a NSCLC cell population. It up-
regulated miR-186, which was found to directly inhibit the
cyclin-dependent kinase 1 (CDK-1) expression with
subsequent destabilization of the cellular cycle (Li L. et al., 2019).
POLYSACCHARIDES
Polysaccharides are a vast class of biogenic polymers formed by
monosaccharide units connected by glycosidic bonds. These
compounds consist of anywhere between 40 and 3,000 linked
monosaccharides that are either connected to form linear
structures or branch out into side chains (Zong et al., 2012).
In plants, they are mainly involved in energy storage or they play
a structural role. Many compounds have qualities that allow
various medical applications. Some even have anti-cancer
properties, with potential uses ranging from dietary
supplements for disease prevention, to antioxidants,
immunomodulators, apoptosis inducers and metastasis
inhibitors (Yu et al., 2018). Polysaccharides are produced by a
variety of organisms, from microorganisms (e.g., bacteria, fungi)
to animals, plants and marine algae. In this section, we will only
focus on the plant-derived ones, mentioning compounds which
have a mechanism of action involving ncRNAs.
A homogenous polysaccharide extracted from the leaves of the
tea shrub (Camellia sinensis (L.) Kuntze), referred to as green tea
polysaccharide was shown to have anti-proliferative and anti-
migratory effects on prostatic cancer both in vitro and in vivo.
Upon treatment with green tea polysaccharide, miR-93 levels
were down-regulated and the Bax/Bcl2 ratio and caspase-3
expression were increased but no direct target of miR-93 nor
any potential cellular pathways were explored (Yang et al., 2019c).
However, in a follow-up study, the same author group revealed
disabled homolog 2 (DAB2) as a potential target of miR-93. Up-
regulation of DAB2 would act in an inhibitory fashion on the Akt/
ERK1,2 pathways, accounting for the observed anti-proliferative
and anti-metastatic effect (Yang et al., 2019d).
Besides the tea shrub, another source of polysaccharides with
proven anti-cancer activity is the plant species Patrinia
heterophylla Bunge (Lu et al., 2010), which is used in TCM in
a form known as Patriniae Herba. The aqueous extract of
Patrinae Herba which most probably contains polysaccharidic
compounds, showed anti-proliferative, anti-metastatic properties
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in hepatocellular carcinoma cell lines, via up-regulating the
lncHTR2A-AS1 and subsequently influencing the concentration
of several proteins–MMP2, P21, caspase 3, E-Cadherin (Guan
et al., 2020).
Promising natural products also originate from plants of the
genus Actinidia, whose most famous representative is the vine
producing the kiwifruit. Experiments using Actinidia eriantha
Benth. polysaccharide (AEP) on a murine leukemia virus-induced
tumor, showed potential immunomodulatory properties of AEP
on macrophages by influencing lncRNAs (D730047E02Rik,
Gm14047, A_30_P01020139, A_30_P01026293 and
A_30_P01032196), which could subsequently modulate the
mRNA expression of different genes implicated in the immune
response. In this study, a predicted target was the NF-κB p65
protein, which could account for the macrophagic activation
observed in the cell lines (Chen X. et al., 2019).
The only compound studied in pediatric cancers was the
Angelica sinensis polysaccharide (AP). AP is a polysaccharide
found in the root of Angelica sinensis (Oliv.) Diels, commonly
known as dong quai or female ginseng. In a study on
neuroblastoma cells, AP treatment resulted in increased
apoptosis (as evidenced by higher expression of Bax, caspase-3
and -9 and lower expression of Bcl-2) and reduced migration and
proliferation (Yang J. et al., 2018). MiR-675 levels were down-
regulated and transfection with a miR-675 mimic reduced the
effects of AP. Mechanistic studies were performed and miR-675
was shown to up-regulate the PI3K/AKT and JAK/STAT
pathways, and AP down-regulated these pathways by down-
regulating miR-675. Another study treating neuroblastoma
cells with AP revealed the same pro-apoptotic and anti-
proliferative effects already described and showed that the
PI3K/AKT and ERK1/2 pathways were inhibited. MiR-205 was
up-regulated and, after transfection with a miR-205 inhibitor, the
effects of AP were reduced (Yang et al., 2019b). MiR-205 was
shown to target the ZEB1 gene which is known to induce EMT in
various cancers (Eger et al., 2005).
The Mongolian milkvetch (A. membranaceus) does not only
yield the astragalosides discussed in the saponins section, but also
a mixture of polysaccharides that were shown to have anti-
proliferative effects. Chu et al. treated osteosarcoma cell lines
with Astragalus polysaccharide (APS), resulting in up-
regulation of miR-133a, which in turn led to decreased
expression of several proteins of the JNK pathway, a member
of the MAPK pathway, implicated in cell proliferation and
apoptosis. In this study, the authors observed that APS also
promoted cell cycle arrest in the S phase and apoptosis, and
the anti-migratory effect was reflected by lower measured levels of
MMP-2 and -9 (Chu et al., 2018).
There is an additional plant extract worth mentioning that has
been shown to contain compounds from various classes (phenols,
flavonoids, triterpenes) along with polysaccharides. It is the Spica
Prunellae extract (SPE), obtained from Prunella vulgaris L., a
plant commonly known by the very fitting names of self-heal or
heal-all. In a study on colon cancer cell lines, treatment with SPE
showed anti-proliferative and apoptosis inducing properties via
up-regulation of the miR-34a which, in turn, was shown to
decrease the expression levels of Notch1,2 and Bcl-2 (Fang Y.
et al., 2017). Moreover, in a different study using bioinformatic
analysis, the same extract showed 5-FU chemo-sensitizing
properties in colon cancer cell lines, supposedly via up-
regulation of miR-494, which could down-regulate TOP 2α
expression, an enzyme involved in DNA transcription (Fang
et al., 2019).
ORGANOSULFUR COMPOUNDS
Organosulfur compounds are a chemically heterogeneous group
of organic molecules that contain sulfur. In human diets, two
major sources of organosulfur compounds are represented by
vegetables from Alliaceae (garlic, onions, leaks etc.) and
Brassicaceae (cabbage, Brussels sprouts, kale, broccoli,
cauliflower, watercress etc.) families. These organosulfur
compounds, such as alliin (onions) or glucosinolates (Brassica-
species), protect plants from pathogens and insects. A side aspect
is that these compounds are key for the taste of the plant-based
foods. Moreover, they have health-promoting effects as part of
the human diet. In a 2016 review by Biersack (2016) the interplay
between three major organosulfur compounds and miRNAs in
adult anti-cancer therapy was precisely described. However, over
the last four years, more insights were gained, with some few
studies also focused on pediatric-age cancers.
Diallyl disulfide (DADS), a compound found in garlic and
other plants in the genus Allium, showed anti-proliferative
effects in gastric cancer cell lines and tumor bearing mice via
up-regulation of miR-200b and miR-22 which directly target the
Wnt1 pathway (Tang et al., 2013). Likewise, in a different study
on gastric cell lines, DADS up-regulated miR-34a, which, in
turn, led to down-regulation of p-PI3K and p-Akt, resulting in
apoptosis induction and invasiveness reduction (Wang G. et al.,
2016). In a different study employing breast cancer cell lines
and tumor bearing mice, DADS also increased miR-34a
expression and was shown to directly target c-Src, affecting
its downstream targets Ras/ERK. This led to reduced
proliferation and invasiveness in vitro, as well as to reduced
tumoral volume in mice models, compared to the control groups
(Xiao et al., 2014).
A further agent with potent anti-cancer activity is
sulforaphane (SFN), an organosulfur compound found in
many vegetables of the Brassicaceae family. SFN showed
varied anti-cancer properties, ranging from cancer cell
stemness suppression, anti-proliferation and apoptosis
induction to metastasis and EMT inhibition and can be used
as a chemo-sensitizing co-agent in a wide range of cancers.
In a study on two colon cancer cell lines, SFN treatment has
effectively decreased miR-21 and human telomerase reverse
transcriptase (hTERT) mRNA levels, by means of epigenetic
regulation showing anti-proliferative and apoptosis-inducing
effects (Martin et al., 2018). In another recent study on colon
cancer cells, the co-treatment of SFN and a miR-15b-5p
inhibiting agent, showed very potent anti-apoptotic properties,
compared to the two substances alone (Gasparello et al., 2020). In
a study on two gastric cancer cell lines and a control cell line, SFN
dose-dependently increased miR-9 and miR-326 expression in
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one cell line. These miRNAs targeted and reduced the expression
of the caudal type homebox 1 and 2 (CDX1, CDX2) protein levels,
which are known to act as modulators of intestinal stem cell
differentiation. The observed phenotypic effect was apoptosis
induction (Kiani et al., 2018).
In pancreatic cancer, one study done on different cell lines
showed that SFN induced miR-135b-5p expression which, in
turn, binds to the 3′UTR region of the Rat sarcoma (RAS) Protein
Activator Like 2 (RASAL2) gene, leading to its up-regulation,
having an anti-proliferative effect in vitro. These findings mirror
the expression levels found in tumor tissues compared to healthy
tissue (Yin et al., 2019a). In a different in vitro study on pancreatic
cancer, SFN alone or in combination with other natural
compounds (quercetin and green tea catechins), were shown
to have anti-proliferative effects through up-regulation of the
miRNA let-7 and subsequent down-regulation of its target K-Ras
(Appari et al., 2014). In a different study miR-365a-3p was
significantly underexpressed in pancreas cancer tissue
compared to healthy pancreas tissues. The group showed the
ability of SFN to induce miR-365a-3p expression and confirmed
c-Rel as target, known to act on NF-κB signaling. In this study,
SFN treatment showed anti-metastatic and apoptosis-inducing
properties in vitro, confirmed by decreased tumor size in
xenograft models (Yin et al., 2019b).
Interestingly, the chemoresistance of pancreatic cancer might
be partly owed to a decreased intercellular communication
through gap junctions and reflected in low connexin 43
(Cx43) expression. In one study on pancreatic cancer cells,
SFN treatment inhibited miR-30a-3p expression, which was
shown to target Cx43 and increase its expression, which led to
better gemcitabine chemosensitivity (Georgikou et al., 2020).
Lung cancer stem cells showed high expression rates of miR-
19a and mir-19b, which were significantly decreased by SFN
treatment. These miRNAs were shown to target GSK3β, which
affected the downstream Wnt/β-catenin pathway. This way, SFN
showed stemness suppression, alteration of tumor sphere
formation and resulted in apoptosis induction (Zhu et al.,
2017). In a different study on NSCLC, SFN decreased the
expression of a different miRNA, miR-616-5p which was then
shown to also target GSK3β and influence the aforementioned
pathway. In this study, treatment with SFN was effective in
suppressing EMT and reducing metastatic potential (Wang D.
X. et al., 2017). The SFN treatment in NSCLC cell lines was shown
to also up-regulate miR-214 expression, which was shown to
target the c-Myc proto-oncogene, leading to stemness inhibition,
apoptosis induction and to better cisplatin chemosensitivity
in vitro as well as in vivo (Li et al., 2017).
In an in vitro study on bladder cancer, SFN induced the
expression of miR-200c which, in turn, targeted ZEB1, leading
to increased E-cadherin expression, suggesting that SFN acts as a
TME modulator in this type of cancer (Shan et al., 2013). In
nasopharyngeal carcinoma, SFN increased miR-124-3p levels,
which down-regulated STAT3, resulting in decreased
proliferation and apoptosis inducement (Li X. et al., 2018). In
a different study on gastric cancer cell lines, SFN also up-
regulated miR-124-3p. This miRNA in turn targeted IL-6R
and STAT3 which resulted in better response to cisplatin
treatment, especially by counteracting the stemness-inducing
properties of the treatment with cisplatin alone (Wang X.
et al., 2016).
A study on AML showed that sulforaphane might reduce the
pathologically up-regulated miR-155, and hereby induce
differentiation and apoptosis, however, there is no mechanistic
explanation of this effect (Koolivand et al., 2018). In GBM cell
lines, SFN has been shown to repress the Wnt/β-catenin/TCF4
pathway and indirectly decrease the miR-21 expression. This
down-regulation then altered the BAX/BCL-2 ratio and increased
caspase 4 and 7 levels, with pro-apoptotic consequences. This
effect was especially useful in the Temozolomide treated cells,
acting as chemosensitizer (Lan et al., 2015).
Effects related to lncRNAs were reported by a study which
investigated a prostatic cancer cell line and compared it to a non-
cancerous control before and after SFN treatment using whole
genome RNA sequencing. Significant differences in expression of
about 100 lncRNAs involved in cancer metabolism, cell cycle
regulation and signal transduction were noted. Moreover, the
suppression of LINC01116 through SFN showed anti-
proliferative effects by modulating expression of several genes
implicated in metabolism (GADPH), autophagy (MAP1LC3B2)
and regulation of chromatin structure (H2AFY). The authors
hypothesized that this LINC01116 could modulate target genes
expression by forming ssRNA:dsDNA triplexes with them
(Beaver et al., 2017).
Lastly, another organosulfur compound found in Brassicaceae,
phenethyl isothiocyanate (PEITC) has been shown to increase
the expression of miR-194 in prostate cancer cell lines. This
miRNA, in turn, targets and decreases the expression of the bone
morphogenic protein 1 (BMP-1), resulting in decreased levels of
MMP2 and 9 which are associated with a lesser migratory
potential (Zhang C. et al., 2016).
The presented findings regarding organosulfur compounds
are summarized graphically in Figure 3.
Summing up, in this entire segment, we presented natural
compounds from different chemical classes and reviewed their
ncRNA-dependent anti-cancer effects. In order to visualize
the most important information presented in the main
body of this review, we created a table that lists most of the
cancer types discussed herein, along with two or more examples
of natural compounds studied for each cancer, the ncRNAs which
are known to be involved in each particular case and, wherever
available, with their downstream targets (Table 2). Additionally,
Figure 4 summarizes our review in a graphical manner: phenolic
acids and other monophenols, flavonoids and curcuminoids in
Figure 4A; tannins, terpenoids, saponins, stilbenoids and
carotenoids (except for ATRA, already presented in Figure 2)
in Figure 4B; polyprenylated acylphloroglucinols, cannabinoids,
alkaloids, polysaccharides and organosulfur compounds in
Figure 4C.
FUTURE PERSPECTIVES
In this review, we summed up recent findings related to anti-
cancer plant-derived natural compounds that have a ncRNA
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(mostly miRNA)-related mechanism of action. In our search,
several points raised our attention.
First, most studies were in vitro analyses, using cancer specific
cell lines and researching the effects of treatment with the specific
natural compound, compared to treatment with a negative
control substance. Hence, only exceptionally the effect of a
natural compound was compared to an already proven anti-
tumorigenic substance. Expression levels of specific ncRNAs were
then measured via microarray or PCR. Likewise, levels of
potential mRNA targets and/or the corresponding proteins
were subsequently analyzed. In some cases, direct targeting
was confirmed via luciferase reporter assay. Rescue assays, to
ensure that the noted effects were indeed induced by the studied
substances via ncRNA and their downstream pathways were
rarely performed. Few studies also confirmed the finding in
vivo, using tumor-bearing mice models. Unfortunately, this
thorough analysis was not conducted in all studies and we
want to point out that in order to introduce these substances
into clinical practice, comprehensive mechanistic studies are
necessary.
Second, we observed that natural compounds can have
heterogenous anti-cancer effects by restoring dysregulated
ncRNA expression levels and, in turn, indirectly targeting
numerous downstream molecules of ncRNAs. Natural
compounds can act as anti-proliferative, apoptosis-inducing
and anti-metastatic agents, but can also influence the TME,
the energetic metabolism, angiogenesis and lastly, induce
chemosensitivity (Figure 5). An important limitation of the
studies we analyzed is the fact that only exceptionally the
mechanism through which the natural compound regulates
the ncRNA expression was researched. We can envision
several possibilities: the natural compound directly/indirectly
regulates the transcription of the ncRNA; the natural
compound inhibits the biogenesis of ncRNAs, in a similar way
to small-molecule inhibitors of miRNA (Vo et al., 2014); or the
natural compound binds the mature form of ncRNA prolonging
its half-life or accelerating its degradation. Apart from these
putative mechanisms, many of the reviewed compounds are
known to have effects on membrane fluidity and permeability
(Tsuchiya, 2015). As already described for terpenoids, this could
account for certain, presumably unspecific effects of
phytochemicals on miRNA function by influencing membrane
association of AGO proteins. Deciphering these aspects is of great
importance in order to understand the mechanism of action of
natural compounds on ncRNAs in cancer and could help in
improving the efficacy of semi-synthetic natural compound
analogs or derivatives.
Third, we only focused on pharmacological products that
where directly derived from natural compounds, excluding
those synthetically designed based on natural compounds.
However, there are compounds derived from plants, which are
further synthetically adjusted (for example ATRA), which have
shown solid anti-oncogenic capacities and some of which are also
clinically used. This observation clearly outlines that after the
initial confirmation of the anti-cancer effect of natural
compounds, subsequent synthetic modifications that improve
the pharmacokinetics and pharmacodynamics of the
compound are necessary in order to translate the findings into
clinical practice. Of note, in order to purposefully make synthetic
modifications that improve the pharmacodynamics of the natural
FIGURE 3 | The mechanism of action of sulforaphane by modulating expression of several miRNAs (yellow rectangles) which target specific molecules (blue ovals)
and/or pathways (purple rectangles), inducing the observed phenotypical changes–inducing of apoptosis, inhibition of cell proliferation, inhibition of metastasis, inhibition
of EMT, TME modulation and inducing of chemosensitivity.
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compound, it is crucial to understand its biomolecular
mechanism of action. Therefore, in-depth mechanistic studies
are highly necessary.
Fourth, we noticed that some of the reported substances were
used in phase I-III clinical trials, with sometimes inconclusive and
sometimes favorable results. While there are several phase I trials
that proved the therapeutic efficacy of natural compounds, only
few phase II trials reported favorable outcomes. Many of the
phase II clinical studies were terminated due to lack of safety,
funding, or lack of efficacy. Nevertheless, there are also a few
phase III clinical trials that are either completed or currently
recruiting. Data regarding some very popular compounds that
potentially also function via ncRNAs is already available. A phase
II clinical study on curcumin showed beneficial effects on
reducing radiation-induced dermatitis in breast cancer patients
(Ryan et al., 2013). A phase III study on the same topic was
completed by the same study group, but no results have been
published (NCT01246973). In contrast, a phase II clinical study
on resveratrol (SRT501) in combination with bortezomib on
refractory multiple myeloma patients showed no efficacy and
several concerning adverse side effects (nausea, vomiting, and
renal failure), having an unacceptable safety profile (Popat et al.,
2013). Two phase III clinical trials regarding treatment with
curcumin in prostatic cancer are currently recruiting. One of
them measures the progression of low-risk prostatic cancer
(NCT03769766), while the other assesses recurrence post
radical prostatectomy (NCT02064673). A phase II clinical trial
on curcumin in advanced inoperable pancreatic cancer has been
completed in 2020, results are still to be published
(NCT00094445). Unfortunately, only scarcely do these studies
report mechanistic analyses regarding the anti-tumorigenic effect
of the natural compounds. We can only speculate that natural
TABLE 2 | Types of cancers covered in this review and some of the most representative examples of natural compounds/derivatives acting on ncRNAs, the type of material
studied on (cell lines, i.e., in vitro or mouse models i.e., in vivo), the mechanistic pathway downstream of the ncRNA and the phenotypic effect achieved.









Apigenin 1 miR-520b ATG7 CS Gao et al. (2018)
Dauricine 1, 2 miR-199a HK2, PKM2 A, CS, E Li W. et al. (2018)
Gastric cancer Luteolin 1 miR-34a BCL-2 A Wu et al. (2015a)
Sulforaphane 1 miR-124–3p IL-6r, STAT3 CS Wang X. et al. (2016)
Colorectal cancer Astragaloside IV 1 miR-29c B7-H3 P Wang et al. (2018)
Astragaloside IV 1 miR-134 CREB1 EMT, CS Ye et al. (2017)
Pancreatic cancer Luteolin 1 miR-301–3p Caspase-8 P Moeng et al. (2020)
Sulforaphane 1, 2 miR-135b-5p RASAL2 P Yin et al. (2019a)
Non small-cell lung
cancer
Garcinol 1 miR-200b let7 E-cadherin, vimentin, ZEB1 EMT, CS Farhan et al. (2019)
ATRA 1 miR-512-5p p21 A, E Chu et al. (2016)
Oral squamous cell
cancer
Sophocarpine 1, 2 miR-21 PTEN, p38/MAPK P, A, EMT Li W. et al. (2017)
Ginsenoside Rg3 1, 2 miR-221 TIMP3, PI3K/AKT, MAPK/ERK P, EMT Cheng and Xing (2019)
Nasopharyngeal
cancer
EGCG 1 miR-296 STAT3 M Lin et al. (2020)
Sulforaphane 1 miR-124–3p STAT3 P, A, TME Li X. et al. (2018)
Prostatic cancer Sulforaphane 1 LINC01116 GADPH, MAP1LCD3B H2AFY E, GS, A Beaver et al. (2017)
PEITC 1 miR-194 BMP-1 MMP2, -9 M Zhang C. et al. (2016)
Breast cancer Betulinic acid 1 miR-27a ZBTB10, Sp-1, -3, -4 P, A, AG Liu et al. (2012);
Mertens-Talcott et al. (2013)
Ailanthone 1 miR-148a CyclinD1, p53 and p21 Caspase-3, -9
AMPK, Wnt/β-catenin
P, M Gao W. et al. (2019)
Neuroblastoma Angelica sinensis
polysaccharide
1 miR-675 KIF1Bβ, CD44, lncRNA-H19 P, A, M Yang J. et al. (2018)
EGC, EGCG 1 miR-7-1 A Chakrabarti et al. (2013)
CML Capsaicin 1 miR-520a-5p STAT3 P, A Kaymaz et al. (2014)
AML Ginsenoside Rh2 1,2 miR-21 BCL-2 A Wang and Wang (2015)
Osteosarcoma Resveratrol 1 miR-139-5p NOTCH1 A Xiao et al. (2020)
Nephroblastoma Triptolide 1 miR-193b-3p KLF4, PI3K/AKT, ERK A, M Hang et al. (2019)
Salidroside 1 miR-891b Cyclin D1, MMP-2, vimentin, p53, p21,
caspase-3, -9 PI3K/AKT/mTOR
P, A, M Li H. et al. (2019)
Retinoblastoma Curcumin 1 miR-22 Erbb3 P, M Sreenivasan et al. (2012)
Shikonin 1 miR-34a,
miR-202
MYCN P Su et al. (2018)
Medulloblastoma Ligustrazine 1 miR-211 PI3K/AKT and mTOR P, M Xu D. et al., 2018
Triptolide 1 miR-138 CDK6 P, M Zhang H. et al., 2018
Glioma/GBM Xanthohumol 1 miR-4725–3p STIM1 P, EMT Ho et al. (2018)
Apigenin 1 miR-16 BCL-2 - NFkB/MMP9 A Chen X. J. et al. (2016)
Resveratrol 1 miR-21 IκB/p50-p65 P Li H. et al. (2013)
BBMD3 1 miR-4284 JNK/AP-1 A Yang F. et al. (2014)
aApoptosis; A, Inhibition of Angiogenesis; AG, Anti-proliferation; P, Inhibition of metastasis; M, Inhibition of Epithelial to mesenchymal transition; EMT, Regulation of tumoral
microenvironment; TME, Regulation of cellular energetics; E, Promotion of genomic stability; GS, Inducing chemo-sensitivity; CS.
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FIGURE 4 | Summarized in this figure are natural compounds (ovals), which influence specific cancers (big rectangles) through specific ncRNAs (long rectangles):
(A) phenolic acids and other monophenols, flavonoids and curcuminoids; (B) tannins, terpenoids, saponins, stilbenoids, carotenoids (except for ATRA, already
presented in Figure 2); and (C) polyprenylated acylphloroglucinols, cannabinoids, alkaloids, polysaccharides and organosulfur compounds.
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compounds function in clinical setting via ncRNAs. Meanwhile,
methodological tools for investigating molecular interactions of
natural compounds with ncRNAs are readily available. For
instance, we highly recommend the analysis of ncRNA
expression on tumor biopsies after neoadjuvant treatment/
palliative treatment with natural compounds and/or the
analysis of the circulating ncRNAs from the different bodily
fluids before and after treatment with natural compounds.
The future and the role of natural compounds in medicine
and more precisely in oncology remains undetermined. In a
recent critical publication Grollman and Marcus (2020)
presented the historical development and the current status
quo regarding the use of “botanical medicine”. Mainly, the use of
herbal remedies is rooted in ignorance or lack of knowledge
regarding potential side effects or rejection of evidence-based
medicine, especially in western societies. Most concerningly, the
authors emphasized the complex financial interests regarding
regulation of dietary supplements. Funding of the WHO
through the Chinese government, lack of regulation
regarding safety profiles, the planned introduction of TCM
and alternative medicine in the 2021 ICD-11 are all current
critical problems and raising awareness regarding this topic is
essential. While the authors emphasized the hazardous effects in
the unregulated use of “herbal remedies”, the intrinsic effects
and potentiality of these compounds is presented in many of the
studies mentioned above. That being said, we do not advocate
for the uncontrolled use of such compounds as “health
boosters”. We do support, however, an evidence-based
approach in the use of such compounds mainly as adjuvant
treatments in specific cancer types where the effect is proven,
with acceptable safety profiles documented in phase III and IV
clinical trials. Surely, many further mechanistic investigations
regarding such compounds are needed until official clinical
approval of one such substance will take place.
Taking a look toward the future, we would like to conclude
with noting the auspicious coexistence of three aspects: the
overwhelming diversity of chemical compounds produced
throughout the plant kingdom, the accumulating evidence
linking several such compounds to ncRNA-mediated anti-
cancer effects and the availability of the proper methodological
FIGURE 5 | The general mechanisms bywhich plant-derived natural compounds (phytochemicals) influencemiRNA expression. In turn, thesemiRNAs can alter the
expression of different proteins implicated in several cancer signaling pathways by binding to target mRNA. This alteration at the molecular level then leads to the
phenotypical changes observed in vitro and in vivo. Themajor phenotypical changes are represented in the figure. Lastly, the major types of natural compounds and their
pathways of action are summarized in the figure.
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tools for investigating their exact mechanism of action. In this
combination, we recognize promising circumstances for the
development of reliable, evidence-based cancer treatments
starting from natural compounds. There are good reasons to
expect that scientific efforts invested in this topic, while still
abundantly needed, will eventually prove to be worthwhile.
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